<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta content="width=device-width, initial-scale=1, maximum-scale=1, user-scalable=no" name="viewport">
    <meta name="description" content="نظام معلومات الأدوية السعودي Saudi Drugs Information System">
    <meta name="author" content="Saudi Food & Drug Authority (SFDA)">
    <noscript><meta http-equiv="refresh" content="0; url=/noScript.html" /></noscript>
    <link rel="shortcut icon" href="/favicon.ico">
    <title>&#x646;&#x638;&#x627;&#x645; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</title>
    <link href="/fonts/roboto/roboto.css?v=53F8z0aw8DRnG9ou9x1tuKMPbNjRZWM-VBHl3B0s9-o" rel="stylesheet" />
    <link href="/fonts/material-icons/materialicons.css?v=8pEJ8MWsFzHRDLY0NI5rssf6T6vankxrJDPnnZxOGrg" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-rtl.css?v=0env-Atj9mTPLILmJGwuDlLIOS_Akxxy4gnH1UUtrjU" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-glyphicons.css?v=U5a39oen_WYzVAAexH5aoahbpqlKHcIzQrnXujf1yio" rel="stylesheet" />
    <link href="/lib/bootstrap-select/dist/css/bootstrap-select.css?v=DeY2lH0e0tmNnO9XZ-gGVOGk6_YoWlZ49y7CnD3ST00" rel="stylesheet" />
    <link href="/lib/toastr/toastr.css?v=kKePN_CyxTiMEgsSDu_7z21ru07YOZtR-0UV0JOkt5o" rel="stylesheet" />
    <link href="/lib/famfamfam-flags/dist/sprite/famfamfam-flags.css?v=JVJiF3s2_kk99xQHfYhfxo_-Dd52ZIruDMOILwPkqv0" rel="stylesheet" />
    <link href="/lib/font-awesome/css/font-awesome.css?v=YIHlqxkiJtENTMuzIHC9EfZaB5RniGr7kF7juUQJUuc" rel="stylesheet" />
    <link href="/lib/Waves/dist/waves.css?v=nd3hxjNg6DhkuFIz5IbxLK8Xw2ac0blsDQpF4pkJxUc" rel="stylesheet" />
    <link href="/lib/animate.css/animate.css?v=IT6GQizZpVcaM1_L_mIiNAYVvZErMgfwewf1GGWXG_I" rel="stylesheet" />
    <link href="/css/materialize.css?v=ey-J3xahkqficOYUHVX3jexmzvRFrge9bmux4CQr1DQ" rel="stylesheet" />
    <link href="/css/Publicstyle.css?v=xhOiVjq-54ODzSIeHXoascHsEJm_n_bIHqZatpxnYhg" rel="stylesheet">
    <link href="/css/Comman.css?v=bcS6_IRqBsBcY1mS_iriWWanrYR0Scdo1ffk8rQGXwQ" rel="stylesheet" />
    <link href="/css/themes/all-themes.css?v=eGSl5zNTWrXYfUx_EJW9ksC3CUTUUxvxmPiA3aQDtQo" rel="stylesheet" />
    <link href="/view-resources/Views/Shared/_Layout.css?v=BLxBuNISlF2O5EBHWdsX039NvnIHy-GtcqeI_MbyIc0" rel="stylesheet" />
    <link href="/lib/enjoyhint/enjoyhint.css?v=rSxIyBbiAvx_48ZcFxbn2DNPCCgEc0FXa2Vb72enxk4" rel="stylesheet" />
    <link href="/lib/dropzone/dropzone.css?v=IQDlHJdeYZ4gMH87EuB1yEG7ujA7DSEkV_SWfACk8Rg" rel="stylesheet" />

    <!-- View specific styles -->
    
    <script type="text/javascript" nonce="c7f26c8w">
        // This is used to get the application's root path from javascript. It's useful if you're running application in a virtual directory under IIS.
        var abp = abp || {};
        abp.appPath = '/';

    </script>
    <style>
        .popover .popover-title {
            text-align: right;
            font-weight: bold;
        }
        .popover .popover-content {
            text-align: right;
            font-size: 14px;
            font-family: 'Almarai', sans-serif;
            color: black;
        }
       
    </style>
</head>
<body>
    <!-- Page Loader -->
    <div class="page-loader-wrapper">
        <div class="loader">
            <div class="preloader">
                <div class="spinner-layer pl-blue">
                    <div class="circle-clipper left">
                        <div class="circle"></div>
                    </div>
                    <div class="circle-clipper right">
                        <div class="circle"></div>
                    </div>
                </div>
            </div>
            <p>&#x628;&#x631;&#x62C;&#x627;&#x621; &#x627;&#x644;&#x625;&#x646;&#x62A;&#x638;&#x627;&#x631; ...</p>
        </div>
    </div>
    <!-- #END# Page Loader -->
    <!-- Overlay For Sidebars -->
    <div class="overlay"></div>
    <!-- #END# Overlay For Sidebars -->
    <!-- Search Bar -->
    <!-- Top Bar -->
    <nav class="navbar navbar-inverse naav" style="margin-bottom: 0;">
        <div class="container-fluid">
            <div class="navbar-header">
                <button type="button" class="navbar-toggle" data-toggle="collapse" data-target="#myNavbar">
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                </button>
            </div>
            <div class="collapse navbar-collapse rtl" id="navbar-collapse">
                <ul class="nav navbar-nav navbar-right">
                    <li><a href="/home/DrugSearch">&#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</a></li>
                        <li><a href="/Account/Login"><i class="fa fa-key"></i>&nbsp;&#x62A;&#x633;&#x62C;&#x64A;&#x644; &#x627;&#x644;&#x62F;&#x62E;&#x648;&#x644;</a></li>
                </ul>
                <ul class="nav navbar-nav navbar-left">
                    <li class="dropdown">
    <a href="javascript:void(0);" class="dropdown-toggle" data-toggle="dropdown" role="button">
        <i class="famfamfam-flags sa" title="&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;"></i>
        <span>&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</span>
        <b class="caret"></b>
    </a>
    <ul class="dropdown-menu pull-right">
                <li><a href="/AbpLocalization/ChangeCulture?cultureName=en"><i class="famfamfam-flags gb"></i> English</a></li>

    </ul>
</li>

                </ul>
            </div>
        </div>
    </nav>
    <section id="mainContent" class="content">
        <nav class="navbar naav" style="margin-bottom: 0;">
            <div class="container-fluid">
                <ul class="nav navbar-nav">
                    <li>
                        <a class="text-center" href="/">
                            <img src="/images/logo_sdi.png" style="margin: auto;" width="250">
                        </a>
                    </li>
                </ul>
                <div class="navbar-header navbar-toggle2 ">
                    <button type="button" class="navbar-toggle navbar-toggle2" data-toggle="collapse"
                            data-target="#myNavbar2">
                        <span class="icon-bar icon-bar2 "></span>
                        <span class="icon-bar icon-bar2"></span>
                        <span class="icon-bar icon-bar2"></span>
                    </button>
                </div>
                <div class="collapse navbar-collapse " id="myNavbar2">
                    <ul class="nav navbar-nav">
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover" data-placement="bottom" title="" data-content="موقع الكترونى يمكن شركات ووكلاء الادويه من رفع النشرات الممارس الصحى ونشرة معلومات المريض وصورة عبوة الدواء المعتمدة من الهيئة العامة للعذاء والدواء بهدف بناء مرجع وطنى للادوية المسجلة يمكن الرجوع له من قبل الممارس الصحى والمريض كمصدر موثوق للمعلومات الدوائية"
                               data-original-title="&#x645;&#x646; &#x646;&#x62D;&#x646;">
                                &#x645;&#x646; &#x646;&#x62D;&#x646;
                            </a>
                        </li>
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover"
                               data-placement="bottom"
                               title=""
                               data-content="&#x627;&#x630;&#x627; &#x643;&#x627;&#x646; &#x644;&#x62F;&#x64A;&#x643;&#x645; &#x645;&#x644;&#x627;&#x62D;&#x638;&#x627;&#x62A; &#x627;&#x648; &#x627;&#x642;&#x62A;&#x631;&#x627;&#x62D;&#x627;&#x62A; &#x64A;&#x631;&#x62C;&#x649; &#x627;&#x644;&#x62A;&#x648;&#x627;&#x635;&#x644; &#x639;&#x644;&#x649;   SDI@SFDA.GOV.SA"
                               data-original-title="&#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;">
                                &#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;
                            </a>
                        </li>

                    </ul>
                </div>
            </div>
        </nav>
        

<div class="col-xs-12">
    <div class="row text-center">
        <a href="/" class="btn bg-blue btn-lg m-b-10 hover-white">&#x628;&#x62D;&#x62B; &#x62C;&#x62F;&#x64A;&#x62F;</a>
    </div>
</div>
<div class="jumbotron" style="margin-bottom: 0px; background-color: white !important;">
    <h3 class="text-center" style="color: #57aabf; ">Search Results</h3>
    <hr width="20%" style="border-top: 3px solid #54ae90;">

    <br>
    <table class="table s-row">
        <thead style="margin-bottom: 30px !important">
                <tr>
                    <th id="M" style="color:white;">
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x627;&#x644;&#x645;&#x645;&#x627;&#x631;&#x633; &#x627;&#x644;&#x635;&#x62D;&#x64A;</a>
                    </th>
                    <th id="A" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</a>
                    </th>
                    <th id="E" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x627;&#x646;&#x62C;&#x644;&#x64A;&#x632;&#x64A;&#x629;</a>
                    </th>
                    <th id="f" class="active-tab" type='button'>
                        <a href="javascript:void(0)" style="color: white;">&#x635;&#x648;&#x631; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>
                    <th id="D" style="color:white; background-color: #47a4ba;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x628;&#x64A;&#x627;&#x646;&#x627;&#x62A; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>

                </tr>
        </thead>
    </table>
    <div id="D-div" class="box-data" style="display: block;">
        <div class="row">

<div class="modal-body rtl">
    <div class="tab-content">
        <div role="tabpanel" class="tab-pane m-r-60  animated fadeIn active" id="edit-user-details">
<div class="row clearfix">
                    <div class="col-lg-6 col-md-6 col-sm-6">
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="RegisterNumber">&#x631;&#x642;&#x645; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        2609245952
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="RegisterYear">&#x633;&#x646;&#x629; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        2003
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="TradeName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x62A;&#x62C;&#x627;&#x631;&#x64A;</label>
                                    <div class="form-line">
                                        RELAXON CAP
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="ScientificName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x639;&#x644;&#x645;&#x64A;</label>
                                    <div class="form-line">
                                        CHLORZOXAZONE,PARACETAMOL
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label " for="Strength">&#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        250,300
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="StrengthUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        mg
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="AdministrationRouteName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x625;&#x633;&#x62A;&#x639;&#x645;&#x627;&#x644;</label>
                                    <div class="form-line">
                                        Oral use
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PharmaceuticalFormName">&#x627;&#x644;&#x634;&#x643;&#x644; &#x627;&#x644;&#x635;&#x64A;&#x62F;&#x644;&#x627;&#x646;&#x64A;</label>
                                    <div class="form-line">
                                        Capsule
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Size">&#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="SizeUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageSize">&#x62D;&#x62C;&#x645; &#x627;&#x644;&#x639;&#x628;&#x648;&#x629;</label>
                                    <div class="form-line">
                                        30
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageTypeName">&#x627;&#x646;&#x648;&#x627;&#x639; &#x627;&#x644;&#x639;&#x628;&#x648;&#x627;&#x62A;</label>
                                    <div class="form-line">
                                        Blister
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="LegalStatusName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x635;&#x631;&#x641;</label>
                                    <div class="form-line">
                                        Prescription
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="ProductControlName">&#x62D;&#x627;&#x644;&#x629; &#x627;&#x644;&#x645;&#x631;&#x627;&#x642;&#x628;&#x629;</label>
                                    <div class="form-line">
                                        Uncontrolled
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="DrugTypeName">&#x646;&#x648;&#x639; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</label>
                                    <div class="form-line">
                                        Generic
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="ShelfLife">&#x645;&#x62F;&#x629; &#x627;&#x644;&#x635;&#x644;&#x627;&#x62D;&#x64A;&#x629; &#x628;&#x627;&#x644;&#x623;&#x634;&#x647;&#x631;</label>
                                    <div class="form-line">
                                        36
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="StorageConditionsName">&#x634;&#x631;&#x648;&#x637; &#x627;&#x644;&#x62A;&#x62E;&#x632;&#x64A;&#x646;</label>
                                    <div class="form-line">
                                        store below 30°c
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Price">&#x633;&#x639;&#x631; &#x627;&#x644;&#x62C;&#x645;&#x647;&#x648;&#x631; &#x628;&#x627;&#x644;&#x631;&#x64A;&#x627;&#x644;  ( &#x627;&#x644;&#x633;&#x639;&#x631; )</label>
                                    <div class="form-line">
                                        24.15
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Manufacture_NameEn" name="Manufacture.NameEn" value="Jamjoom Pharmaceuticals Factory Company" />
                                        <label class="form-label" for="Manufacture_NameEn">&#x627;&#x644;&#x645;&#x635;&#x646;&#x639;</label>
                                        <div class="form-line">
                                            Jamjoom Pharmaceuticals Factory Company
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Agent" name="Agent" value="[Agent 394]" />
                                        <label class="form-label">&#x627;&#x644;&#x648;&#x643;&#x64A;&#x644;</label>
                                        <div class="form-line">
                                            JAMJOOM PHARMACEUTICALS CO. LTD.
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <label class="form-label" for="Company_NameEn">&#x627;&#x644;&#x634;&#x631;&#x643;&#x629; &#x627;&#x644;&#x645;&#x633;&#x648;&#x642;&#x629;</label>
                                        <div class="form-line">
                                            Jamjoom Pharmaceuticals Factory  Company
                                        </div>
                                    </div>
                                </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode1">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 1</label>
                                    <div class="form-line">
                                        M03BB53
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode2">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 2</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                    </div>
                </div>
        </div>
    </div>
</div>

        </div>
    </div>
    <div id="E-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> SFDA PIL</span>
                <span style="font-size:small;">  (Patient Information Leaflet (PIL) are under review by Saudi Food and Drug Authority)</span>

            </div>
</div>


<div class="clearfix ltr">
    <div class="col-lg-12 col-md-12 col-sm-12 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="InventedNameEn">1. What this product is and what it is used for</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Chlorzoxazone is a centrally acting skeletal muscle relaxant. It acts<br />primarily at the spinal cord level and subcortical areas of the brain where it<br />inhabit multisynaptic reflex areas involved in producing and maintaining<br />skeletal muscle spasm of varied etiology. This results in reduced skeletal<br />muscle spasm. Relief of pain and increased mobility of involved muscles.<br />Paracetamol is analgesic and antipyretic. It is as potent as aspirin in<br />inhibiting prostaglandin synthesis in the CNS. The analgesic action of<br />paracetamol adds to that which results secondarily from muscle relaxation.<br />Relaxon&trade; capsule offers quick relief of pain and restores mobility even in<br />severe painful spasms of skeletal muscles.</p><p>Relaxon&trade; exerts a fast pain relief and it is indicated as an adjunct to rest, physical&nbsp;therapy, and other measures for the relief of discomfort&nbsp;associated with acute, painful musculoskeletal conditions.</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="form-group clearfix">
            <label style="float: left" class="h2" for="PrecautionsEn">2. What you need to know before you use this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>Do not take Relaxon&trade;</strong><br />&bull; If you are taking any other products that contain paracetamol.<br />&bull; Relaxon&trade; capsule is contraindicated with known hypersensitivity to any<br />components of the preparation.<br />&bull; Avoid in patients with liver disease.</p><p><strong>Take special care with Relaxon&trade;</strong><br />Suffering from G-6-PD deficiency (a hereditary condition leading to low<br />red blood cell counts).<br />Serious (including Fatal) hepatocellular toxicity (as it has been reported rarely in patients receiving chlorzoxazone).<br />The mechanism is unknown but appears to be idiosyncratic and<br />unpredictable. Factors predisposing patients to this rare event are not known. Patients should be instructed to report early signs and/or symptoms of hepatotoxicity such as fever, rash, anorexia, nausea, vomiting, fatigue, right upper quadrant pain, dark urine, or jaundice.<br />Chlorzoxazone should be discontinued immediately and a physician consulted if any of these signs or symptoms develops. Chlorzoxazone use should be discontinued if a patient develops abnormal liver enzymes ( e.g. AST, ALT, Alkaline phosphatase and bilirubin). The concomitant use of alcohol or other central nervous system depressants has an additive effect. If a sensitivity reaction occurs such as urticaria, redness or itching of the skin, the medicine should be stopped.<br /><strong>If any signs or symptoms</strong> suggestive of liver dysfunction are observed, the medicine should be discontinued. Dosage in excess of the recommended ones may cause severe liver damage.<br /><strong>Patients suffering from kidney disease</strong> should take this medicine under medical supervision.</p><p><strong>Using other medicines, herbal or dietary supplements</strong><br />The medicinal products that may interact with chlorzoxazone include zolpidem, citalopram, duloxetine, gapapentin, clonazepam, pregabalin, oxycodone, topirama, tramadol and alprazolam.<br />Alcohol and other CNS depressants: They cause drowsiness that may be additive to that induced by chlorzoxazone.<br />They also may increase the potential of hepatotoxicity of paracetamol.</p><p><strong>Using Relaxon&trade; with food and drink</strong><br />Meals have no influence on Relaxon&trade;.<br />Pregnancy and breast-feeding Safety of chlorzoxazone during pregnancy or lactation has not been<br />established. Ask your doctor for advice before taking any medicine.</p><p><br /><strong>Driving and using machines Relaxon&trade;</strong></p><p>should not be taken for drivers (as chlorzoxazone causes drowsiness).</p><p>&nbsp;</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="AdministrationRoutesEn">3. How to use this product.</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Always take Relaxon&trade; exactly as your doctor has told you.<br />You should check with your doctor if you are not sure.<br />The usual adult dosage is two capsules to be taken 3 times daily.</p><p>For oral administration and short-term use only.</p><p>Do not take more than 14 capsules in 24 hours.<br />Do not take with any other paracetamol-containing products.</p><p>Do not give to children under 6 years of age.</p><p>Do not exceed the stated dose.</p><p><strong>If you take more capsules than you should:</strong></p><p>Talk to a doctor at once if you take too much of this medicine,&nbsp;even if you&nbsp;feel well. This is because too much paracetamol can cause delayed, seriou sliver damage.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsEn">4. Possible side effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Like all medicines, Relaxon&trade; can cause side effects, although not<br />everybody gets them.<br />Occasional GI disturbances, dizziness, nausea, lightheadedness or<br />drowsiness, malaise or over stimulation may be noted.<br />Rarely, a patient may note discoloration of urine resulting from a phenolic<br />metabolite of chlorzoxazone.<br />Adverse events of paracetamol are rare and usually mild ,although<br />haematologic reactions including thrombocytopenia,leucopenia ,<br />neutropenia and agranulocytosis have been reported.<br />Skin rashes,and other hypersensitivity occur occasionally.<br />Prolonged excessive use or abuse of paracetamol can produce nephropathy.<br />Even patients who exceeded the recommended doses, pancreatitis<br />associated with paracetamol was rare.<br />Ingestion of 15g of paracetamol may cause hepatocellular necrosis and less<br />often, renal necrosis.<br />If any of the side effects gets serious, or if you notice any side effects not<br />listed in this leaflet, please tell your doctor.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsEn">5. How to store this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Keep out of the reach and sight of children.<br />Do not store above 30 &ordm;C.<br />Do not use Relaxon&trade; after the expiry date which is stated on the carton.<br />Do not use Relaxon&trade; if you notice change in medicine color or odour.<br />Medicines should not be disposed of via wastewater or household waste.<br />Ask your pharmacist how to dispose of medicines no longer required.<br />These measures will help to protect the environment.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. Further information</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsEn">a. What this product contains</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Each capsule contains:<br />Active ingredients are Chlorzoxazone 250 mg and Paracetamol 300 mg.<br />Inactive ingredients are colloidal silicon dioxide, crospovidone, magnesium<br />stearate, sodium lauryl sulphate, titanium dioxide, allura red, tartrazine and<br />gelatin.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsEn">b. What this product looks like and contents of the pack</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                Orange opaque cap and white opaque body, hard gelatin capsules, printed
with 'Jamjoom' on cap and 'Re 1' on body in black, filled with white to off
white homogenous granules.
Relaxon™ available in pack containing three blisters of 10 capsules each.
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingEn">c. Marketing Authorization Holder and Manufacturer</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Jamjoom Pharmaceuticals Co., Jeddah, Saudi Arabia.<br />Tel: +966-12-6081111, Fax: +966-12-6081222.<br />Website: www.jamjoompharma.com<br />To report any side effect(s):<br />&bull; Saudi Arabia:<br />- The National Pharmacovigilance and Drug Safety Centre (NPC)<br />o Fax: +966-11-205-7662<br />o Call NPC at +966-11-2038222<br />Exts: 2317-2356-2353-2354-2334-2340.<br />o Toll free phone: 8002490000<br />o E-mail: npc.drug@sfda.gov.sa<br />o Website: www.sfda.gov.sa/npc<br />&bull; Other GCC States:<br />&minus; Please contact the relevant competent authority</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteEn">d. This leaflet was last revised in {MM/YYYY}</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                02-2016
            </div>
        </div>
    </div>
</div>    </div>
    <div id="A-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> نشرة الدواء تحت مراجعة الهيئة العامة للغذاء والدواء</span>
                <span style="font-size:small;">  (اقرأ هذه النشرة بعناية قبل البدء في استخدام هذا المنتج لأنه يحتوي على معلومات مهمة لك)</span>
            </div>
    <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr">

    </div>

</div>
<div class="clearfix rtl">
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="InventedNameAr">1. ما ھو هذا المستحضر وماھي دواعي استعماله</label>
        </div>
        <div class="form-group clearfix" style="float: right">
            <br />
            <p style="text-align:right">كلورزوكسازون هو مستحضر باسط للعضلات الإرادية يعمل بشكل مركزى حيث يعمل بمنطقة<br />النخاع الشوكى و ما تحت القشرة المخيه وذلك يثبط الوصلات العصبية بالمسارات الإنعكاسيه و<br />المسئوله عن إحداث و إستمرار التقلصات العضليه التى تنتج من أسباب مختلفة مما يؤدى إلى قلة<br />تشنجات العضلات الهيكلية، زوال الألم و زيادة حركة العضلات المعنية.</p><p style="text-align:right"><br />يتميز الباراسيتامول بتأثيره المسكن و الخافض للحرارة الذى يضاهى التأثير المماثل للأسبرين<br />فى منع تكون البروستاجلاندين فى الجهاز العصبى المركزى مكملا بذلك التأثير المسكن الناتج<br />بشكل ثانوى لإرتخاء العضلات و الذى يحدثه الكلورزوكسازون.</p><p style="text-align:right">كبسولات ريلاكسون &trade;تزيل الألم سريعاً و تستعيد القدرة على الحركة حتى فى حالات تقلص<br />العضلات الهيكليه الشديد و المؤلم.</p><p style="text-align:right">ريلاكسون&nbsp;يقوم بتخفيف الآلام سريعاً ويوصف كعامل مساعد للراحة والعلاج الطبيعي، وغيرها من التدابير للتخفيف من التوتر المصاحب لحالات ألم الجهاز العضلي الهيكلي.</p><p style="text-align:right">&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="PrecautionsAr">2. ما الذي يجب عليك معرفته قبل استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p style="text-align:right"><strong>لا تتناول ريلاكسون في الحالات التالية:&nbsp;</strong></p><p style="text-align:right">إذا كنت تتناول أي من المنتجات الأخرى التي تحتوي على الباراسيتامول.</p><p style="text-align:right">لا يجب استخدام كبسولات ريلاكسون&nbsp;لأشخاصالذين يعانون من فرط الحساسية لأى من مكونات هذا الدواء&nbsp;</p><p style="text-align:right">لا يجب استخدام كبسولات ريلاكسون للأشخاص الذين يعانون من امراض الكبد.&nbsp;</p><p style="text-align:right"><strong>أعط عناية خاصة عند تناول ريلاكسون في الحالات التالية:</strong></p><p style="text-align:right">تعاني من نقص G6PD وهي حالة وراثية تؤدي الى نقص كرات الدم الحمراء.</p><p style="text-align:right">تم رصد بعضالحالات النادرة للتسمم الكبدى و التى قد تكون خطيرة فى قليل من المرضى<br />المستخدمين لمادة الكلورزوكسازون.<br />ولا يعرف سبب ذلك على وجه الدقه و لا يمكن توقعه كما لا تعرف العوامل التى تساعد على<br />حدوث هذه الحالة و لذلك فيجب التنبيه على المرضى بالابلاغ عن المظاهر المبكرة للتسمم<br />الكبدى مثل: إرتفاع درجة الحرارة ، الطفح الجلدى ، فقدان الشهية ، الغثيان ، القئ ، التعب ،<br />حدوث ألم بالجانب الأيمن من أعلى البطن ، تحول البول إلى اللون الداكن أو إصفرار بالجلد. فى<br />هذه الحالة يجب إيقاف إستخدام مادة الكلورزوكسازون فورا و إستشارة الطبيب عند حدوث أى<br />من هذه العلامات أو الأعراض.<br />،AST يجب إيقاف إستخدام مادة الكلورزوكسازون عند حدوث إرتفاع فى إنزيمات الكبد مثل<br />إنزيم ألكالين فوسفاتيز و البيليروبين. قد يكون الإستخدام المتزامن مع الكحوليات أو ،ALT<br />غيرها من مثبطات الجهاز العصبى المركزى له تأثير إضافى.<br />إذا حدث رد فعل تحسسى مثل الشرى (أرتيكاريا)، إحمرار أو حكة الجلد، يجب وقف العلاج.<br />إذا لوحظ ظهور أى علامات أو أعراضتوحى بضعف وظائف الكبد، يجب وقف العلاج.<br />الجرعة الزائدة قد تسبب ضرر شديد بالكبد.<br />المرضى الذين يعانون من مرضفى الكلى يجب أن يتناولوا هذا الدواء تحت إشراف الطبيب.</p><p style="text-align:right"><strong>تناول أدوية أخرى، أدوية عشبية أو مكملات غذائية&nbsp;</strong></p><p style="text-align:right">المنتجات الطبية التي قد تتفاعل مع كلورزوكسازون تشمل زولبيديم، سيتالوبرام، دولوكستين ،<br />جابابنتين، كلونازيبام، بريجابالين، أوكسيكودون، توبيراما، ترامادول و ألبرازولام.</p><p style="text-align:right">الكحول و مثبطات الجهاز العصبى المركزى الأخرى: يسببوا النعاس بالإضافة إلى النعاس الذى<br />يتسبب فيه كلورزوكسازون.<br />كما قد يزيدوا من إحتمال حدوث تسمم الكبد الناتج عن تناول الباراسيتامول.<br /><strong>تناول ريلاكسون &trade;مع الطعام و الشراب </strong><br />تناول الوجبات لا يؤثر على ريلاكسون&trade;.<br /><strong>الحمل و الرضاعة</strong><br />لم يتم التأكد من أن استخدام كلورزوكسازون آمن أثناء الحمل و الرضاعة.<br />استشر طبيبك قبل أن تتناول هذا الدواء.<br /><strong>قيادة المركبات و تشغيل الآلات</strong></p><p style="text-align:right">لا يجب للسائقين تناول ريلاكسون لأن كلورزوكسازون يسبب النعاس.&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            https://localhost:44358/Dashboard
            <label class="h2" for="AdministrationRoutesAr">3. ماھي طريقة استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>قم دائما بتناول ريلاكسون كما اخبرك الطبيب&nbsp;تماماً. يجب أن تتحقق من طبيبك إذا كنت غير متأكد من الاستخدام.</p><p>الجرعة المعتادة للكبار هى ۲ كبسولة ثلاث مرات يومياً.<br />للتناول عن طريق الفم والإستخدام على المدى القصير فقط.<br />لا تتتاول أكثر من ۱٤ كبسولة في ۲٤ ساعة.</p><p>لا تتتاول مع أي من المنتجات الأخرى التي تحتوي على الباراسيتامول.</p><p>لا تعطي للأطفال أقل من العمر ٦ سنوات . لا تتجاوز الجرعة المذكورة.</p><p><strong>إذا تناولت كبسولات أكثر مما يجب:</strong></p><p>تحدث إلى الطبيب فوراًً إذا كنت تناولت الكثير من هذا الدواء، حتى لو كنت تشعر أنك بخير. هذا لأن الكثير من الباراسيتامول يمكن ان يسبب ضعف او تلف خطير للكبد.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsAr">4. الأعراض الجانبية المحتملة</label>
        </div>
        <div class="m-r-60">
            <p>كما هو الحال مع جميع الأدوية، من المحتمل ظهور أعراض جانبية لريلاكسون لكنها لا تصيب كل الاشخاص.</p><p>تصيب كل الأشخاص.<br />&bull; أحيانا يحدث إضطراب فى الجهاز الهضمى، دوار، غثيان، نعاس، توعّك أو تنبيه مفرط.<br />&bull; بشكل نادر، قد يلاحظ المريض تغير لون البول يسببه المستقلب الفينولى للكلورزوكسازون.<br />&bull; الأعراض الجانبية للباراسيتامول نادرة و عادة ما تكون خفيفة، بالرغم من أنه تم الإبلاغ عن<br />حدوث بعض التأثيرات على الدم تشمل نقص الصفيحات، نقص عدد خلايا الدم البيضاء، نقص<br />العدلات و ندرة المحببات.<br />&bull; الطفح الجلدى و أعراض الحساسية الأخرى قد تحدث فى بعض الأحيان.<br />الاستخدام المفرط لريلاكسون &trade;الذى يستمر لفترة طويلة أو إساءة استخدام الباراسيتامول قد&nbsp;<br />يؤدى إلى إعتلال الكلى.<br />&bull; حتى الأشخاص الذين تعدوا الجرعة الموصى بها، التهاب البنكرياس المصاحب لاستخدام<br />الباراسيتامول يكون نادر الحدوث.<br />&bull; تناول ۱٥ جرام من الباراسيتامول قد يسبب نخر الكبد و فى حالات أقل حدوثا نخر كلوى.<br />إذا وصلت أحد الآثار الجانبية لهذا الدواء لمرحلة الخطر أو ظهرت آثار جانبية جديدة لم تذكر في<br />هذه النشرة يرجى اخبار الطبيب أو الصيدلي.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsAr">5. طريقة تخزين المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>يحفظ بعيداً عن متناول و مرأى الأطفال.<br />يحفظ فى درجة حرارة لا تزيد على ۳۰ م. &ordm;<br />لا تتناول ريلاكسون&trade; بعد انتهاء فترة الصلاحية المكتوبة على العلبة و على الشرائط .<br />لا تتناول ريلاكسون &trade; إذا لاحظت أى تغيير فى لونه أو رائحته.<br />اسأل الصيدلي عن طريقة التخلصمن الأدوية التي لم تعد بحاجة إليها. لا ينبغي التخلصمن<br />الأدوية عبر إلقائها فى بالوعات الصرف أو فى مخلفات المنزل&nbsp;ستساعد هذه التدابير في حماية<br />البيئة.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: right">6. معلومات أخرى</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsAr">أ‌. على ماذا يحتوي هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p><strong>ما هي مكونات كبسولات ريلاكسون</strong><br />كل كبسولة تحتوي على:<br />المواد الفعالة هى كلورزوكسازون ۲٥۰ ملجم و باراسيتامول ۳۰۰ ملجم.<br />المواد الغير فعالة هى ثانى أكسيد السيليكون الغروى، كروسبوڤيدون، ستيرات الماغنسيوم،<br />كبريتات لوريل الصوديوم، ثاني أكسيد التيتانيوم، أحمر اليورا، التارترازين والجيلاتين.</p><p>&nbsp;</p><p>&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsAr">ب‌. كيف يبدو شكل هذا المستحضر وماهي محتويات العلبة</label>
        </div>
        <div class="m-r-60">
            <p style="text-align:right">كبسولات ريلاكسون ذات جزء علوي&nbsp;برتقالى غير شفاف والجزء الآخر السفلي أبيض غير شفاف</p><p style="text-align:right">مطبوع عليها كلمة `Jamjoom` على الجزء العلوي وكلمة `Re1` على الجزء السفلي باللون الاسود كبسولات جيلاتينية صلبة مملوءة بحبيبات متجانسة لونها ابيض الى مائل للأبيض.</p><p style="text-align:right">كبسولات ريلاكسون متوفرة في شرائط تحتوي على 10 كبسولات في علبة بها ثلاثة شرائط.&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingAr">ت‌. الشركة المصنعة ومالك حق التسويق</label>
        </div>
        <div class="m-r-60">
            <p><img src="data:image/jpeg;base64,/9j/4AAQSkZJRgABAQEAYABgAAD/2wBDAAMCAgMCAgMDAwMEAwMEBQgFBQQEBQoHBwYIDAoMDAsKCwsNDhIQDQ4RDgsLEBYQERMUFRUVDA8XGBYUGBIUFRT/2wBDAQMEBAUEBQkFBQkUDQsNFBQUFBQUFBQUFBQUFBQUFBQUFBQUFBQUFBQUFBQUFBQUFBQUFBQUFBQUFBQUFBQUFBT/wAARCAFoAloDASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwD9U6KKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiqEOvabcaxcaTFf20mqW8azTWayqZo0YkKzLnIBwefar9ABRRXMan8S/DGi69faLfaxb2uqWViupz20jYZbYsUEnuNwx+I9aOtg6XOnopAcgEdKWgAooooAKKKKACioZ7y3tWRZp44mc4VZHClvpnrXPaX8TPDGtalcWFlrNtPe2+oNpUsCt8yXSxmQxEf3tgLfShauy/r+rh/X9fcdPRXPeNtS8QaVpKzeHNKtdXvfMCvFeXX2eNE5y5bB6ccVraTPcXWmWk13HHFdSRK0scL70ViMkK3ce9G9w7FuiiqL65p0esR6S99brqkkRnSzaVRM0YOC4TOSAT1oAvUUUUAFFYOp+OtB0bxJpugXuqW9vrGpJNJaWjt88wiUNJj3CsDj0qn4J+KXhX4jIG8Oa1basPs6XR8hskRs7oCfT5o3H1U099gOqooprOsa5ZgozjJOKQDqKpXmsWen3lja3FwkVxfSNFbxseZGClyB9FUn8Ku0AFFUNJ17TdeW5bTb+2vxbTPbz/AGeVX8qVThkbB4YHqDV+gAooooAKKKpR6zZS6xNpaXMbahDClxJbg/MsbllViPQlGH4UAXaKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKAOX8Q2vjCbxf4cm0W/0q38NRNL/bNteQO9zOCv7ryHB2rhuu4HIr5k+Jvx18Y/Dv8Aaw0TUNc8WWXhz4FPDLYTXd7CFtXvEjLMjSkZV92AGzt4YdQa+nPEHgG08R+LPDviCfUdVtrjQ2leG1s7xoracyLtPnxjiTA6Z6HmvBte8M/G3wvrmo+GtO8F+DPib4B1DUZr62m168+zSaesshkKSxNG4l2u74KjOMUlpKPz9O2vyd10v+N6OLv5evXb5287P5lbVf2yPgZpHxIuNb0/xX4M1O4l0OVTqWnXKyahPLHIhS1+UEsGBJUcnKmqPjr/AIKAeAr63Oh+CPHvg6y8Qy2azvq/iK+Mem2TsPuHHzSyA5+RcYx8xFfQHhv4S+E9Pt9PvJ/BHhew1uJEeSTTtNh2xTY58t/LDYBzg4BqeX4N+AJ5Hkk8DeG5JHYsztpFuSxPUk7OTTcdOX+t2/1/D1JTV+b+un+X4nzXon/BQrwnD8E49UuPEHhzxL8RIfMt5dJ0u98mCV0kZBOSwJihZVDgt/eAGSar+JPjd8PP2idO1Wfwn4h0jUdW1DwHfG8sbaVZLuykVoZEWTHzDaxcfUV9UaT8NfCGgmc6Z4V0TTjcR+VMbTToYvMTOdrbVGR7GjRvhr4R8O3Ek+k+FdF0yeSMxPLZ6dDCzIeqkqoJB9Kq95OXXp5aNfqOL5WtNE/v1T/C3+dzV0CaS40HTpZQRK9tGz567iozXjXhv48XuuftQ698PBdaQ2mWNkcWCFxqUUyLE5ncH5TC4l2rjnMZ9a9i8QaHH4i0eewkubmy8wfJcWUpjmiYcq6N6g4PII9QRXmPwh/Z5Hw58Xat4t17xZqXjzxZex/ZI9X1WCGKW3tNwZYFESqDyBljycDpQnzVHJ7a/jt/Xz30M0uWnyrV6f8AB/r9D0ltat76/wBT01BN/okIM88fAQsCQoP97Az7ZHrXx/8ACn9s74beHNH8fadP4u0vQtZs7hm0v/hJPEf2wXo8srGWOAY3ymHiHKkjPJr1n4ifCr4w6b441jxB8KPHOhabba20Ut9pHirT5LmCOVIxH5kLRsGUsqoCp44zWT4f/ZP1a+huNU8XeINAufFN9Isl3NpXhazW2VQrfJGsqM2S7li7Es2BnpURTd3e11b8f6+XmbPlj563/DZ/1+Bq/tCftD3nwy+DfhzxVpl1o+l3mtGCSO41xnW0VTCZ2jLLyGdVMaE8bnBNQ6f+3h8GLzUHt38eaLFCLOKeO5NxmKeZt26CJsYd1wuVUk/MOK0PiB+yvB8Q9esI77xnrK+BI2WW78FGOCSxuXU5XDsm+Nc8lVOOcDaK9Qj+GXg+G2s7dPCmhpb2chmtol06ELBIcZdBt+VuByOeKvR3eyb+aX9f1qzLaMY9UtX3f9aHy94x/a6+Cviq1utY1fU/C9v4s8PXcKWdhruoGOYp+4llKoCCHBLKAR96LnitXS/GXg/4i+LJdb8C65pfiS1t/HGnXxvNJdZEVprX7PIpZerbVYnPY19Eap8K/BWt6hNfaj4P0G/vZm3S3N1pkEkkh9WZlJJ+tX9B8F+HvC0bx6LoOmaRG7iRksLOOAMwGAxCqMnBPNEWk0+1vzTf32CV2mk90196a/C55p+014s8Z6D4a0rTfBvhXWPEc2s3TWd5LoyxmW0hKN8+6QhUy21dxztBJwSBXFeHf21vhd4Y8H+FdN1jxnpMHiGKO3sdYsZbkeZpkipiY3AA+QKylSTgZI9a+mq5x/hx4SkuL+d/C+itPqAK3krafCWuQTkiQ7cuCQDzmoV43Xez+7Zem9ynaVvLT79367fcfInxO/4KHaJfWtzqHw78c+BbLTtHuCbiHxFdMb3WET70dpCnKhugkfrwQMc1kePP25fB3hP41aJ4ybxB8OPFvg54104Po1x5niDSkkALysT9+PdwUXoBnqa+wv8AhS3w9/6EPwz/AOCe3/8AiKP+FK/D3/oQ/DP/AIJ7f/4iqj7tn2/4Z/10HK0k1/Xl9349TRbxdb614BfxJ4aubXVLa4083unz+YFgnUpuQ7j0U8c1y3jH4z2Pgn4X6H401h4dL028Nm13czkmG0SXaWZ2HRRnG48AkE8VzfxU/Zft/iddabZJ4y17w74MjZf7Q8JaU6RWV8i42pkAPEvAyqnaRxgV7AdB01tFXR3sLeXSlhFv9iliDxGMDAQqRgjA6Gk+rXdW9Fv9/wChPVJ9nf52t939XPibwV+0v8NtP8aWniLxH8WfCt0154ivJ4bOfU7W4k0myltWUIZYsqR5iIAckgMAT1A6f4WfHb4UfD3W49b1Lxf4e0fQ9Ttby10/WDOkVrepFqEzKqPwrFVlB9eTX0d/wpX4e/8AQh+Gf/BPb/8AxFXbj4YeDbrTLXTZ/CWhzadaszQWkmmwtFCzfeKIVwpPfA5p7Wt0/wArDlaV/PX8b/5Hkvwv/bA8OfFr43X/AIH0KOG80xbB7ux1iG4DfajGyiX93jKp86lG/iwT0xXpHjbRNI+KR1TwRq1pLcaWLaKe7mguHgeOQvuhCMhBDAxls54wvXNdNb+G9Is7q3uoNLsoLm3i8iGaO3RXij4+RWAyF4HA44FeTfFv9njWfHHi3/hKPB/xN8QfDbXJreO0vZNMiiuYLqJCxTdDKCoYFj8w5xxSdlyq23/Bs/yBXu3e39L/AIJQ8WX+pax8QvC0M+mtYDw34vjtLOXeXN1ayaa+XP8AwJ2Bz/dqp8fP2nbb4K/FTwfo+p63oGh6BcgTaq2sytFNLDIxjVrdvu/u2G589iMV6N8M/hDa/D/w3d6ffazqXivUr+Zrm/1jV5c3E8rIELLtwIwFGAqYwK4i3/ZTstU+JCeJPGfirUviBpViWbRvD/iC2t5YNOZ12ud4QNLx0D9OOpGarXmir6LV+eiuvm9f8g0cXpZ2svvbv9z/AOHPm34sftOfCTUtaufDmm+L7PTvCeua8ZNTu/hnebdSuka2QrPKY1LACUOrlBnhPevrH9m/XNM1T4fw2uhN4svdCsj5Vnq3jBXF1eIedyl1V3QZADMOffFdfpfwt8F6HfR3mm+ENB0+8j+5cWumQxSL9GVQRVnxt4VbxhoUtjDq2oaDectb6lpkgSa3fBAYBgVbqeGBBz+NJNRi0lf/AIFkv60B+9JX0/r+vuPK/gn8eL34nfFr4h+HZbrSLiw0WYLa29iX+12eyV4XS6DcbmMfmKRxtcVznxe/bg8KfBX476N4G8RT6VbaNdRAXurf2pH52nzMMp51v95YyMZcn+Ie9eh/A/4DwfCAaxqN/r134w8Xa1Ir6n4i1CCKGa5CZEa7IwFAUE+5JPNS6P8ABXwxN4m8WahrnhLQ9Ul1DUBcw3l7p8U8zoYkyGZ1J4cOB7Yo2cV2Wvm/6e/kDafO7Wu9PJf1+Zw6ft1/CK6tbxrPxfpt3ex3fkwWEcjG4uIdyhrhY8bjGFLPuAxtUmtT4b+KIPHvxU0TxnYQCG08Q+ERI2x/MGI7kmP5hweJXwa9VtvAnhqz1KHULfw7pUF/BF5EV1HZRLLHHjGxWC5C44wDjFadjpdlpcMUNnZ29pFEnlxxwRKioo/hAA4HtRGyafb/ACa/W5MruLitL2/NP9LFqiiikMKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACuWvfEWsw+MbPThp1naaRI+z7deXgEl0xjdikES5JZduW37RjJGcV0GpalbaPp9zfXsy21pbRtLNM/wB1EUZJPsBXhHjT4c+K/EnjTSPifoHik+LdPsJob7SPC6wR28flMmyXy7guAWeN3OXGOgyKF8SvsP7L79D31po1ZgXUFRuYEjgep9qWORZUV0YOjDIZTkEeor5vXxx4t1z4tSapY/Dtpbm20WSy1HRm8RWDyzo86eWwVZCgKlZQd5HDEV3XgWPxP4X+EuuoujQeH9TtWuptK0rU7+OZLeIjdGssqMVChi2OcBQBxijaPM+1/wAbf8H7+wW95RXX/Lr/AF27nrFFfJXhH4rftA/Enw74X8S+GtA0s6LHKyanHctbeZq0aTshks2FxtjJVf4/lPVSQa73WfHXxouL7VG0z4XXFta3Gn+TaLca7Yb7e7BbEhAcgxkEZ5JyvSm1y7+f9fP/AIcFr/X9bf8ADG78TPi3rHw58V6opsrXUNFtfDNxrSwKzJcvLDKisoP3SpWQe4xXoeqa1eQ+HRqOk6W+tXLojxWcc6RFw2Od7kKMA5/CvnjS/BXxE8YXUFv4h8F3OlBdL1eyn1C+1i1ug63TCSOJRG5bCsqjkDAAr2PxJ4H8Q618LrLw3pPil/C2sR21vBJq1vaLcEbFUOFRiBhsEZzkA8UtoWtr+d3L8lYLrmVvO/yUbffqzo/DGrXGoeH4LzUpdP8AtJLrK2nTNJbhlcqQrsATjGDkdQa1xIjSMgZS6gErnkZ6V8r61Y+I/hN8HtZ+HWqeGn17R2W5jtfEA1q0sVlWVzIDsll8xWV3I43cAcmu6+E+q6x4j+KOoanqegv4eltNJi0m/SbVra6ae5Vlkj+WJmwQjSHJxkPVK0pabf8AA/4ZfNEO8Y3e/wDwUvyu/ke4VxHxK8Vaz4WvfCJ0xbNrW/1iKxvhebs+VIrAbCvR923GeD075ryn4meMvGlx8X9Y0X4Uy/2rrf8AYka35upY5NO0q4Ew8h5UZ1O5kMoZUJbG044FRzyfGPxb4V8M6L4o8BLJr9lrFle3mu2eo2kViRDdLIzxxea0m0opABGcmph7/K9k2vu5rP8ABFy93mXWz++11+Z7H4B8eHx54I/t+2sGWbzbqEWXmDcXhmkiK7jgAkx9+Bmsq5+Kv/CJ+C9d8S+MIbXSoNNkUPY2M/2qeHcqFYZcDb5pZwMKSvKnPNJ4H8Aav4Z+Hut6Hb6iukajd32o3FpexxLN9l8+4kkjfYThiN4OCfavK9K+E/ir4daf4n8O6x4bk+NWi+J/Lub+7kmtbJnn2eXJ5sU0uPmVIiCh4IPA4ofW3bT1/rq/KxVknZu6Tf3d/wDhjt/FPxK8dab4DTxCPDlloc0mp2MEVjf3P2h/s0s6xyPKYsqh2sGG0tjnNewV8mN4d+KOlfD/AMR+CtG+GeqnQJokOhx6h4isZJNNcHPlF/NJaEEKVySw5HTFddrniP483HivSNasvBCQaBbyKkvh+PV7Q3EqbWErzSM2zPKlAjcFfm61Wmy6v9Fv/XfoZa2u/wCvT+vLc9a+LHiDVfCfw18Sa1oiQS6rp9lJc28dypaNmRd2GA55APSoPAvxAbxdrGuaZLapb3GlLalpI33JMJoRJvXIztzuAz/drxvUrz473uu6w2q+CI9V8Oavp89suj6fq9ogstwURbmkZS0g/ebyCVO5dv3efQ/g14B1zwtfz6nrSRQXF5oWk2c9vG4crc28ciy/MDgj51APfFEVdNvy/W/5L7xzdnFLz/S36np91dQ2Nu89xNHbwIMvJKwVVHqSelUdH8TaV4g0tdS06/hurBnaNbhG+QsrFCMn/aBFcP4yk8a6pqHi3SY/C2n6roLaRv0qS6liaO4vOcxTI5JAztwdpXjk1x9pJ8TJPAM+meJ/AUniuC+klhWy/tSzivLaAKnlmaTcsTsW8w7oyCMJxnNR0bLtqv66X/rz0Pe6K+R9Y1/426SPDcGlaNrFr4yjskij0fVNc0uXTdTEIAlZlDearEEZcNkZ+6a+mvBura5rXhW0vNe0L/hHdbkjPn6Y10lwsTjjAkTIYHqO+DzzVNaNroTs0mQeOtf1fw/pom0nTrW6O12mvL+7W3tbNVUt5kp5Yrxj5ASM+ldBHMPJhMjxh5APutwTjt614R4u+GfxF+Onw/ttM8Ra2PAcwkuYtT0u0gju4NSiY4j/AHiyBkQD3DEjJHasfxJ4p8W31n4J8Ma/4QOiara6rpzLq76/ZCN2ikXzHSMSGQq6JKApXPzYNOK5movq19z/AMu245d10v8Aht5/Pax9KV5z8WtUn0ldA1q103XNftdO1EG5svD6CaQAqV3vGHVnCk/dXPXJBxXMfFL4neNvCfxm8I6DodnpepaRrFrcYsnnVbqWdIpHySW3JGCsY3BWHzHJHGc/S9e+I2g+LNd1bT/g7qEVrqkEbSWZ8QaeE+1qWBlx5uBuUoCRydmcVHaX9aP/AIH5DatdP+r/ANfmeiaf8TLfxNqV3Y6N5ch/sxr23nkzxKrsjxOnVSjBcg881a+EfijUfG3w08Oa5q8dvDqd9ZpNcx2m7y1kI+YDdyMHt2Oa8M8K/D34qeDviNffE/VtEt/EWr6/DLZXfhbRb6GCHTYcxmFlkmKrI/yMHYdSy46V6b8N7q++FvwR+1+LdPk0ebT2up3sYXW6kiiaeRokBjJVm2sg4PWrWkLvfr5avRd9LXsR9q3Tp9y3+aZ6rRXl3wc174kaheeILfx3osFjZJMr6Nfb4UmuoWByskMcj7CuBznJB5AIrx5vjN8QvFGl+PtNvtKvo7fQNTaOTxJ4V1fTrZLVAofyiZ3cPtBG7gHnBCmpejt5X/L/ADKSv99j6yor548B+PvjxD4bnstb+G9vquo5K6drY1mzjiljI+SW5jRyVIyMiLdkDjFc1fax8adF8H6zb+MtP1i1WC6FzD4k0HWtMtwilFDIVm/5ZeZuKqV3bSATkZpvT+v6/EFqfVlFeU/AbxF8T9U0m5s/iX4Xg0m7tj/ourWt9BKt9Hn5WeKNj5cmOoBK+hrK8deMPiffeN7ef4eafYat4W0a4+za3Y3arHdX8mAWW0meRUXYCAxcYzkDJBoatJIS1TZ61a61Hdaze6aLa6jltURzNLAywyBs/wCrc8MRjnHTitGvnfxJqnxR1HxpH4h0r4V6nYXa6LdaYTJr+n7TI7xtBIVEhBCFZPf5+hq9fePPjVqGnWFl/wAKsudOdoVW/v7PXdPeXfjDeQruAAecM3I/uml0Xf8A4L/RX+Y7a/15fqe9VX1Cea1sbia3tmvJ442aO3V1QysBkKCxABJ4yeK+avClz+0FpmmeJNHXw7PN9puVfR9Y8SaxZTzWkGxfMSX7Pje+4NswuBkbjxXqPw+0/wCIGrfBw6d4mu28OeM3jnt01D9zeSwrvYQzOExG0mzaSBxmhr3W1/X/AAwLdX7kmqfFz/hC/Bt/rviu3trSWK9is4dN02f7RMJZdgigkOAolLOAcEqBznFdP4K1TxBrGlvd+IdFi0CeR8w2K3QuJEj2j/WMvy7s54UkYxzXgVv8HfEPg3QvE3hHX/CMvxq0HxFOl/dXj3NtZHz9io4aOWYEEmNWDIeCTjHSvQ/gDa+LfD+m6joniPR73SNHtZVXQ11bUoLy78kqS0LPE7bghGFZjuKkA5xk2rO/y/S/nvf1XbrDurf16fh9z79PW65Hwd8T9I8daxrOn6Vb6mw0qeS1nvLjT5YbZ5Uba6RysoVyD/dzXkfjn4geK1+L3irSvhrpt34uv49Etxdx/wBpQRWGm3nmv5e7zDkMUB3quTjbxXQ+FNS+KHiT4oWN7r3hCfwv4cghYfNq9tcAsYwHVo42OcuFKnsA2cZqI+9Z9Hf+vw+d0VP3brrp+V/1+Vme00UUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUVS1rVE0XSbu/e3urpLeNpTBZQNNM+BnCIoyzegFeJaJ+0ULn4la9Zy+G/HL6ctnYm3tW8MXQMDs04d2GzKhsJyePlOOhpxXM7IrlfK5dv81/me5tfWyXiWjXES3TqXWAuN7KOpC9SKk81CzLvXK/eGen1r5/8AiN4DufC/xo8K+OpNbgmtb7W7ezFvc6arXFt5kTReXHdbwyxMTkx7SCzZz0rb+OngXw3p9xYeO57OWLV7fU9NjuL6O/uIYxAtyoJkjWQRsArN95TwaI+8k33t+X+aJ+1yrtf8/wDI9m8xN+zcu/G7bnnHrS9eRXkn7RXw70LxJ4H1jxHd2E9xrWk6bO1ncWt9cWzKMBiD5Ui7xlQcNkcV6Fa+KNFg0jTbh9Us7e2uoEkt3luEQSIVBBXJ5GCOnrQtvP8Aqw2rW87/AIW/zLum6Xp2irJBp9na2CzSPcPHbRLGHkY5dyABliep6mue8ffC/wAKfE61jsfE2mrqMP3vI+0SwiQDs4jZd68/dbI56Vw3x00PULXxh8NfHGjX00U+l6zDp13bo/7m5srx1ikDL0JBKMD221yP7aXwtk8TaX4S8aWdzfLceGdTh+2WVrey2yXthNKi3ETmNlPTa3X+EjvSSvy+tvTbX01X49h35bu/S/56eun4o+i9Ls7PT9OtrXT4YbexhjWOCG3ULGiAYAUDgAD0qwJEO4BlJU4PPQ+lZMdxofg3TrHTvtNnpNpDEsNtBNMsYCKAAF3HnAxXl/xh8F+F9H1vQvHLW0kGqSa3psM99HfzxxFDMqBniWQRtwQMsp4NV8U0u7t97sR8MXpsvyPaKRmCqSTgDqTXB/Gz4mXnwl8DP4isvDOo+LGiuYIpLDS13SiJ5AryfRQSfwrT+IEa6x4Rm0omSGXWFFkqocSL5gwxGP7q5Jx0ANRra69Pnp/mUrXSZu3el6fdXlrf3VnazXVnua3upolZ4NwwxRiMrkcHHUVD4g0HTPEWmS2uqQLNaspy28xsmRglXUhkOM8qQa5TT9Ph+JnwnvfD+ozyxTTWkuj6g0DlJY5VUxuwPVSfvD2YHvXMfCXw7fePv2b4vCni+7nubtrW70C9vI3KSyrFLJbiQMOQxVAc+ppyWkra22873/4H3jj9lvTWz8v61+49B8D+A/DXw40k6T4a0y20q1LGeSOIlnkY9ZJHYlnJx95iTx1roFuIn2bZEbeNy4YfMPUevWvnn9jP4ev4P+GWtaPrH2i88Q2Wp3Wj32qXV1LPNeRROfJfLs20eXIPlXAHpWd+yX8IY/hP40+JOhXbXepz6TqCjSdSv7yWd1064QSJCquxVArIw+UDOOavRy30tdPvt/mvlczukvO9vzv+KPpf7RFjPmJjds+8Pven1qSvl/wn8H4fBv7Zmu3dw15qeka9pba/p0d1ezNFYXscqRThIt2z5hIrAlSR2xivpLXG1JNJuTo8drLqYT9wl9IyQlv9tlVmA+gNQvgjJ9f87fmmW/jcVsv8r/qXqKz7DWIby8uLHerXtqkbXKxglEZwSAGI56Hjrgj1rjta+M2laDp11dXNneq1vfT2Dw7BvLRRmVmAzypT5hjtR1sv6/q5PS53c93BalBNNHEWzt8xgucDJxn2qWvlfRdAu4da8YaT8UtEll8U6tHfDRPEjXjXFleWxVysMK8C2lSNtuzaGYKTlua7DWPj3beAf+FR2eoyXS23iK2gSaSO2WVWaSNFQlywI+dwSVDYHJwOacVzWXV2/G+n4ahJ8rt2v9ytr876HvNFFFIYUVz/AI08ZweCNNivJ9L1jVlklEQh0XTpb2UHBOSkYJC8denIrzn4J/Gp/G0TafeaP4sF5LqOoIl9qGgz29vHGlxKERpSoVSqKq4PORg800ua9imrR5n/AFv/AJHr8N9bXFxNBFcRSzwkCWNHBaPPTcB0/Gq39kaVcX8mo/YrOS9mh+yPd+UhkeIEnyi+Mlc5+XOM5rwr4e+Bbr4W/tDGyudZt9UXXtHvrwTDTVtriRkuomAnmDnz2UTEAkAheBxXQ3fgfwv8P/jR4Y1GwtZNPutelvhKzX07Qy3DR+YQsLSGNWbEjfKoPWi2kW+t/wA2v0Jejku1vmrJ3Ow8K/CPwZ4P8Tal4h0jSIYtdvB5VzqEs8k823OfLDSMxRckHauB04rtK8b+KHgfwv4b8ZeHvGjWslpql3rlpBdXi306RMWHlIXiEnlEk+WuSueleqza9plvfLYy6jaR3rEBbZ51Ehz0wuc80lrH0dvwT/UJaS+V/wA1+hdV1YsAQSpwQD0rI8WaHYeLPDWraLqDr9jvLd7ef5gCqsCM+x7ivM9J0HUfB/7UGqXFvezzaD4t0Q3k9pK5ZILy1eOLcg/hDRyrkeqVwvxS+D8MP7WngLxZO97qGheI0l03UdLa9mS2S6ghaa3n8tWCtxGykMCOOnNNR5uS+0r/ACtf9Vp6orWPM1utV57P8Ovoz6B1zwXpfijw6uj6xFJe2vlCNnWZ4ZCMYJEkbKy574Io8FeDvD/gHw7a6J4a0620vSYM+Vb23TJPzEkklmJzkkknuavza9plvfLYy6jaRXjYC2zzqJDnphc5rye18DeGvhz8dtAl0q0l09tcs9SeXffzyRSXG+GTCRPIUViDK3yqO9C1l6/pqSlpbsez0jMF6kDnHNcB4s+KF74Y+Kng7wknhfUtRsPECXHma5br/o9jJGu9VkP+0A35Ck+LK3F9bWMGn+Y99p0g1nyYs5lWAg+Wcf3ycDPofSl0T6P9Hr92o7O9uv8AVjv2dVxuIXJwMnvXl2rfCbXtL8RanrHg3x1N4Yi1Kf7Te6dfWCX9oZdu1njUujRlsAnDEEjpVT9oTQ5/iR8D73UPDWqSWuqWKRa7pN3ayYDTQESorY6q2CpB9a6Txv4W/wCFt/B7UNGnuZ9Ol1nS8C4tXKPDIyBlZSPRsflUv3VKVtV+X/Dp6eSGrS5VfSX6f8BrXzZ2dok0FnEtzMs86oBJMqbAxxyduTj6ZqZWDKCDkHkEV578Km1Hxt8D9Bh8TOx1S90lbXUZIW2sZNhjkYEdCSCc1l/sz2Os6H8LY/Duu3b6hd6DfXWkx3chy81vFKywsx7t5ezP0rSS96Ub7fjrr+n3+RC+FN+n4X/Rnqqssi5Uhh6g5p1eO/s+eH9U8C6h4/8ACd5ezahpWn621zpMtw5eRba4RZjGSeu2RpAPavT9ak1aJrI6XFZSx+ePtn2uR0KwYO4x7VO584wDgdeanSyfe34/5dR9Wu1/6+Zp1l+IfDWm+KtNksdTtvtFvIpX5XaN1yMEq6EMpx3Ug1U8C+LIfG3hm01mAIsVzuKoj7ioDEAN6NgDI7HIrya48eWmq/HjXvh7Yx32kS3kKS3OrWl84uhPHHHIAkUisixNG23cg5YMMZ5pPV8rHqrvser+B/Avhz4d6N/Y/hnTLbSrJHLvFBksznktIxJZ2PHzMST610NfO3wd8W6V4TT4kao9jPoljpsYuLy1uruS4MckLTwSHzJCWIP2frnpXbfAX47WXxq0W7L2Y0jxBp0jQ3+nLOs8akMy+ZDMvyyxEqwDr3BB5FXrL7idvvt8z1OiiipGFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAVkWfhizsfE2p67GZft2oQQW8wZsptiMhTAxwf3jZ/CteigfSxna54e07xLaR2uqWcd7BHPHcokg4WSNgyOPcMAR9Kfrmh2HiTSbvS9UtIr/T7qMxT20y7kkU9QRV6ijyC73IGsYHsjZtEr2xj8oxMMqUxjac9RiubvPhR4L1LTdM0++8J6LqNnpkfk2MN9YRXAtk4+WPep2jgdPQV1dFHmJaaIp3Wk2d5awW0tvG1vA8ckUYGFRkIKEAehA/Kl1TS7XWtPnsb6Bbm0nXZJE/Rh6VbooAwfEvgHwx40e3fxB4c0nXXt8+S2pWMVwYs4zt3qcZwOnpVvWvDel+IdDm0bUbCC70uZBE9o6fuyoxgYHTGBjHTFadFACKoVQBwBwKrzabbXN5bXcsKyXFtu8mRuqbhgke5HFWaKAKNjodhpl9f3lrax29zfust1JGMGV1UKGb32gDPoB6VLp+nW2l25gtYlhiLvIVX+8zFmP4kk/jVmigCpY6XaabJdvawLC11Mbicr/HIVVSx98Ko/CiHS7W31C5vo4FS7uURJpR1dU3bQfpub86h/tC9/wCEgFl/ZUv9n/Z/N/tPzo/L8zdjytmd+cc5xjjrmtGjoBUk0u0l1OHUXgVr2GJ4Y5v4lRipZfoSq/lTNctr+80m5h0u+j02/dMQ3Utv56xt6mPcu76ZFXqztW1C9sZ9PS00qXUY7icRTyRzRoLaPBJkYMQWAIAwuTz0o8h+Z55qPhr4jeGvEWr3nhObw5qllq8iXM6a7LPbvbzLEkZ8vykcMhCBsHGDnnmsyP8AZc8K+JGvtS8dwt4p8RahO09zdpc3NtCmVCKkMSSgIAiqu4fMwzk4OK9nophdnmWn/s2/D/TdTsdQj0m+mubGZbi3+161fXCJIvRtkkzKSPcUlv8As2/D61vIriLSLxfKmWdIP7Zvjbq6tuXEJm8vAOMLtwMdK9OoovYQUVDdXAtLWacpJII0LlIkLu2BnCgdT7Vx/wAH/itp/wAZfBq+JNMsb7TrVru4tPs+oxiOdWhkaNtygnbyp4PI70lre3QNlc7asjwz4Zs/CenS2ViZTDJdT3Z85tx3zStK/OOm5zgela9FA+ljPvPD+nahq1hqdxaRy6hYeYLa4P3og42uB7EfypNY8Pabr7WTahZRXbWVwt3bNIuTDKudrqex5P4E1o0UCM/XvD+neKNLl07VrOK/sZSpeGZcqSrBlPsQQCD2IrOvPh54V1DxBFrt14Z0e61yIqY9TmsInuUK/dIlK7gR254roaKPMPIrSadbSahDfNErXcMbRRy85VWKlh+JVfypt5pdpqE1nNcwLNLZy+fAzdY32su4e+1mH41booA5+8+HvhXUvEEWvXfhnR7rXIirR6nNYRPcoV+6RKV3AjtzxV/VPD2m61dadc31lFc3GnT/AGm0kkXLQybSu5T2O1mH0NaNFABVWPTbWPUJ75YVF3NGsUkvdlUkqPoNzfnVqqGl69p+tyXqWF3HdPZTm2uBGc+VKACUPvgj86AI7Hw3pml6O+lWlnHBpz+Zm3TIX52LOB6AljwPWr8MEdvAkMahIkUIqjoABgCpKwPFXjbSvBy2wv5JnursstrZWsLTXFyyjcyxxqCWIGTx2BoA17DT7fS7SO1tYlht4xhY16DnNJZ6fb6eJhbxLEJpGmfb/E7HJNcdo3xa0/xT4ofR9A07UNXht5HivNWig2WVs6hgyea2A7hl2lUyVJ5rH+H3xruPFkllHqvha/0RLp7iBNQDpPZ+fFcPCYmkU5RiVBUMBnOByKaV9gfn0PSYNPt7W6ubmKJUnuCplcdXwMDP4VW1i01K6ksDp2oxWCRXCvcrJbed58QBzGp3LsJOPm5xjpXHab8a9Jv7yztZLDUbKW61+48PRfaIdqtPCkjlw2cFCI2wR3465r0Ojon/AF3G1ZtP+t1+jPOda/Z68Ba9qk+oT6NPbXNwxeX+zdTu7JJHJJLskEqKWJJJbGTnmsOT9kX4VSaxHq7+Hbp9WjjMKag2t35uFjPVBJ5+4L7ZxXpuveKdI8LW6T6vqNvp8bsqIZ5Au5mYKAB1PLAfjWp1pLyBt9TzGb9mn4cXFjZ2knh92t7VXRU/tG6Hmq7tIyzHzczAszHEm4fMfU10vhH4W+FPAN9dXfh7Q7bSJrmJIXW1ysYjUkqiJnai5ZjhQASSTXR300lvY3EsMYmmjjZkjJxuYDIGe2a4L4YfGK3+IdtosU2mzaVquoaNHrLWrusiRxs5TaHHU5H4AjNNNtu39bv9GJ7Xe3/BX62PRKKKKQBRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABXxf8AGbwjc6N8QvHfgTS7zWP7T8e6bHqXhlv7avE+y3kLMLny2EnyKodZdg4IBGMYFfaFVptNs7i+gvZbSCS8twyw3DxgyRhvvBWxkA4GcdcVLV3/AF/W9n8i1Ky/r+vL5nyD4a8Jp+0x8F9b8V2s+u6R4it9Hh0my8nVr238i/tYj5x2rKA+ZDsJYEnYec1xlp8QpNU8YaN4n0+PVI/DXxC0H/hFYYv7Su5Eh1tUQsQnmfu+jR7lwcxMcg5J+8bHTbPS7cwWVpBaQM7SGOCNUUsxLM2AMZJJJPcmq8XhvSYILWGPS7KOG1lM9vGtugWGQkkugx8rZZuRzyfWteZObk1o+nrdS++/32M17seWO62f3W+5pfK/c+Wfi34N034QfEHRUjm1u60Txdos/huK1fXLw/8AE0UK9sysZfkeQKylhjkD3zY/ZVkl14WVt4nub+PXfhpBcaJqc91qFx5M108x2yuWk2y5iUNlwceaMY4r6mvNNs9Qa3a6tYLlreQTQtNGHMUg4DrkcNyeRzzVS78MaPe2eo20+kWFxb6id15DNbIyXLYAzKCMPwAOc8AUoycb38/1t/6VL8Ow5JSSS8v8n+Ufx7nz78SvEdz4T+PviO/n8U6xZ6GPh9d35jhbzorJ0njXz4YQAGfBzzn6gV494f8AEV5pP/CyLC28V6lothP8PItbgk/4SA3VyboM+bgu7OkUj8bkiJUZwMGvqPwr8MdXuviNdeL/ABXDo8EkelNoVlpukvJNB9laUSFpPMRfmO1V2gbQAeTmuob4SeBmtUtT4L8PG2SMwrCdKg2BC24qBsxt3c46Z5rPl/d8t+jX3udv/Sov5eStpzLnu1s0/u5L/wDpLXz9b/J3ghrK/wDF3wS0258W6peWni3wRPLrkcmvy/6XJHDC0bMQ4KMCzDcm0nHJODS/D/xdrWsfDv4F3yeLtTumj8bXGjXMMd9vS6t1muBGk55ZyqxIAS3IPOc5r6uh+EPgS2mt5YfBPh2KW3Ty4ZE0qANEpJJVSE4GWbgep9a4e++B8l9420FbTRvDXhjwZoOqprdtHokRiuru4WJkAljWNY1ALk7gzEhQOM10OalUvayvf/yfm/J2Rjy/u5R8mv8AyTl/Oz/4Y8G1rXNb1L4d6145h17UrL4waf4rksrTSlv5ADELwRR2Zs92xo2hOd2zJzu3Vd8b6xqPiDw/8ZPEOqa/qehfEHwvqskfhuzt9Qkh8qJIomgVLcNsmWZi2dytncQCMV9dN4N0CTxEviBtD01teVPLXVDaRm6C9Nolxux7ZovvBugaprlprN7oem3esWgxb6hPaRvcQj/YkI3L+BrGOkUvL7vh1Xn7r/8AAn5315tW7db+u+j8tfwXy+N/Et5dax41+MsXiPxjq0F1Y+CbDVU06PWTbR6ff+VIzeUsZUrtdRwSc7sNnIqbQPENxceKfh00HjLU7e98ZfDy7vtVmi1XfJLdJFC0csaMWSNwS4GxB0OckV9YX3wp8E6pfXl5eeDtAu7y9/4+rifS4Hkn5B+diuW5A6+grI8S/B/w6NBuT4c8HeFrfX4bR4NNnuNPjhS3YhsYdIyyKCzH5R1J9amTfJKy6dPSa/8Abl/4Cvko7q77b/8Abm//AIC/vZ8v/CTXZl8P/s++ItJ8V6hq3i7WpDba/Dc6pJcJcWQilaZ5oixRDGVXD7VOeMnNc/8ADvWrLwp4c+GniOw8Ryw3158Tb/TZYxqhW3e0luLgPGYQ2xl4VskEgnrgivqH9nP4ID4U/DHTND8QaR4bl8QQWv2C71LSbbP26Efd81nRWbI4KnIrrk+DPw/jjhjXwL4aWOFzLGq6RbgI5xllGzg8DkegrolJRq8y2vf5XTt6WX4sxiuanyve1vnaSv63f/kqPlHT/GTXHxt8HazpnibUntNW8W6npF5f32qmN54lil2wLZBmjjijZAFdgrsVBwQ1crNptxdfs5fFjxp/wtHxYNb8Paxq9jaXkevgLJCsqrHHIMbT93IKhTycEA19zS/DXwhPcTTy+FdEknmnFzJI2nQlnlAIEjHbywBI3HnmoIvhP4Hg0m40uPwb4fj0y4kWWayXS4BDI6/dZk2bSR2JHFYLSNlva3/pP+T9bm7leal53/8ASv8ANeltD5fktdLm+ME3hx/Fep3Gjap8PhrV7CfEEoEt5G6qk4ZXBRtpJIQqpxkgisO38dt8Q/g78JLPUfEmoaprN54Zvb2S3TVWsLeaSJVUXFxdRuJC8ZxiNNxYsSRgV9cr8IPAazeaPBPh0S+UbfeNJg3eWV2lM7Pu7eMdMcVYt/hh4NtLazt4PCWhw29nK09tFHpsKpBIeroAuFY9yOaqXvRa7/5zt9ykv/AVa2lpj7ri10/yin9/K/v1v14D4E+ONQ1r9mbwhq76imseJLjw+J42mlDyXM6xnr3Y5Az+teQ+Bbq5ufg7a/FLw54y1TUPiC+g3j6pocl4063+oeUxEbWzNiFopEO0Iq5Awc5zX1Rp/gfw5pMlg9joGl2b6eJBZtb2UcZtt/3/AC8L8m7vjGe9P0/wboGkazd6vY6Hptlq15/x839vaRxzz/78gG5vxNOo/aSnJac34b/nfX0QqfuKKetvx2/y/Fnyr4ed9P174Sal4T8X6peXHinT5h4s3ao1yPL+yGRrtlkLLbukuACoUZbG01594A15m+HvwS1qXx1q15q+seMbvRr+6m1xmaezeW5DRMu7bj5UO7buGeCARX3JZ/D/AML6a2qNaeG9ItW1QFb9obGJDeA5yJcL+8zk/ez1NZsfwZ+H8KQIngXw0iwSGWJV0i3Ajc4yy/JwflXkeg9KrmXNe2l07fO9vS2nz7aCs/Z8t9bWv8mr+t2n8keZ/sq6sP7S+Knh2HVpdQ07QfFM1rp8FxetdSW1uYon2b3ZnK7mfG4nuO1euXn9h+H9W1DWpZ2TUJIYoZ1+0u+V3ERhYdxUMWbAKqCxIHNTaD4I8OeFbq7utF0DS9Iubs5uZrCyjgeY5Jy7KoLck9fWqniz4b+HvGdpexahp8aT3ghEt9ajybrMT74j5q4b5GG4ZOAe1Rd2jfdJJ/JWb+ZWnM+zbf3u/wCBn+Nfi5ofgfUIdPuYdS1TU5VWT7Bo9jJeXCI2drNHGCwBKsAcdjWB8MfFWo+LPiJ4tv00/wASaf4fks7MwQeINNmsgtwDMsohWUAkbRETgYyaxvCP7PLL40TXvGV7J4ouNMkVtHutRuYbm4i2sxVi4tYnUgEHAdhktnPU+q+KfDf/AAk2lvapqmoaNMQQl7pcqxzR54JXcrL+amjZX3YdeXpp/wAE4z4O/FbVfiLqXi/T9Z8Ov4dvNC1D7KIXZiZI2XcjHco5I5+XK4IwTXBfET4pX9p4i+Jng2J/EmtM+nwy6fN4Y0iW6k0ueWJx5LyRAhTlEkG7BxIe1d7oPwC0Lwp4Tn0XRNV1zSru5kee512G+3ahcyvjfLJI6srMQoGSvAGFxXR/Dv4a6F8L9EfTdEgkAmlNxdXd1KZrm7mb70s0jcux/IdAAOKTV9L9LfPqClZ387/I+b/h/wCJJvhDr0Fz4b8OfEi88PavMZtZ8P33hu8dLK4cbnubRmTKgvndFkg7iRyMHrdM8VaV4T+BPjjUfE2naxomjXGsX7WsWoWklrdt9olLxsqMN0fzucMcAbc9q+jKw/FnhuTxPZWtst/PYJDdR3D+QzKZQh3BCVZTgkAnB5xg5GRRL3lbvp6K6/K2n/DBH3beTv6tJ/nfX/hzw34ceEdQ1v4MfC27h87U9Uh1yPV728mPMzs8vnz5A+629ivQEEV6x8WPHGp+C/DZPh3S4vEHiq7Pl6Xo8sxhF1IBlgXCtsUKCSxGBxnrXbVwXxI8E6/rWqaL4g8Kava6Zr+krNEkWoQmW1uoZQu+KTadyfNGhDrkjB4Oac5czfS7v6aJfp/WworVOWrSt+Lf4tngfxR+KXxA8UaB4X1Xw/4M17w5480sl723fwzdXMe44328V15DBo2IIJBQNlTuGOfZfjd8YtR+D/hvRNaTw5c6xZ3F1FDqDW8cjtaoxA4RFYlizYAOBngkZFdj4Jl8WzafIfF9rotrfBsIuiXM00RXHUmSNCDntg/Wuc1v4GaJ4m8YaZrus6lrOq22mTC5s9DursNp0M4OVm8sKGd1PI3swB6Cm+i87/8AADpfysefax+0J4zj8aaXNa/DTxSPA0r+TPM2iTyXsoKNul8lfmiVGCAB1y4ZiOgy/wCBfhnWhrnhPWZtHv8ASrG30zVbF49SgaCdEN8jW26NhlSyBjg9BX0JRRFqLTtqr/imv1FJcyt6fg7hRRRUjCiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiuX1r4kaJoPjfQvCd5LcLrOtRTTWaJbSPEViAL7pANqcEY3EZ7UdbB0udRRXmngX4xWfj74ja3o2mMs2l2dmkkFzlf30izSRzFRndtBCgEgAkHGa6m++IPh7TbfxDPc6pDFF4fAbU2bP+jAoJAW4/ukHijon3H1ce3/DnRUV4d8U/EXiTR/GNrJp/jSzXTbmfSZYtBW023HlNexxTOJc/MjCQAjHHH49X4j/aF8A+EfidpngDWNfj0/xNqUYe2gnjdYnJOFTzSNgduyk5NNLmSfdtW9P6/AT0u+i6/wBfL7z0aiivOvjl4qk8P+Cb2PT9WTS9daL7VaZGWlWF0aVR9V4/GkGyuz0OSRYY2d2CIo3MzHAAHeqei65p/iTSrbU9KvYNR065TzIbq2kEkci+qsOCK868Sx63pHxMstVn1zTYPD+q26aXDpd2JHeebZLJtUfcDEgcnqAR6VqfAXWv+Eg+Efhq8awtNMma3Mc1nYwrDDDKjMsioigBRuVuBTWqb/rr/wAD7welv6/rqvkd/WfHr+my65NoyX9u2rQwLcyWSyAzJExKq5XqFJUjPtWL8R/id4b+E/hS48R+JtQFhpcDCMusbSu7k4CIiAszewGeDXO6P4iiuvjpd2a6fZCC88N21/aakluq3My+c6ujPjcVAaIhScDJpLV29fyb/QHpFt/1ql+p6ZRXL+PtS8R22jtH4Oi0q88Qq8cos9VmaON4N4EnKgkHGQDjGa4T4n/HHWdIvbfw/wDDnw1a+PfGUhlabT5NUjsYLZIigl3yuD8wLrhQCec8Clv/AF+Pp5h6nsdJuG7bkbsZx3rI8J6pqOs+H7K61jSv7D1V4wbrTTcJcG3fuu9CVb6j1rw3WPGWpap+0e194X+Ht1rtt4fjGia54ik19LOK3EgSXalq7bZigbJY4I3EDNVb3+T+v+GvZX8w3i5f1/Vj6Korw/4jax8WvA3xYtfEGjWdv4s+F09mkepaTDtXULGUNgzwf89RgglOThTjHGd34S/ENZfhCfEniXVY3it7u8jn1An5NqXUkatx0GAPpSWseYTfK7HqdFfKfifxz8ZfhjoXjqz8WG1v9GkM1x4b8XaftDRRgh1guk/hYrlVcDBIx3BPsKzarF8ctHdtauhpGoeHJT/ZG1TAZ4poyZd3UNtmx7j6U4pyt5/5N6/db/gag3a67fjql+tz0uiiikMKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAK5fXdU8Sx+MtE02w8PQX/AIYu4pv7T1aS+WOS0YAeWqxYzJuJIJBGMV1FFHqB87eKP2QtK8P2qXnwh1y4+D+sK80t7faHYR3sl+kmGaN1nJz8yKV545x1rxSb4U/FNrF9Q1f4zfEbTx4gvINEuY5/BNjIzq6HY8qoTtiG8oW7E89K+9KKSS2eqK5uvU+Z9J/ZM8ZSafqcHif42az4onawW10m6k0e1t30qVZYpUmTZ98hoU+VuDivM/jH+yv488VL4f8ACPjT49+LPEdhrV5sgkh8H2bxWs0Y3q7yx4aHocMCOh7V9yUU371r/wBa3+/zEm4qy/rS33eRxngHwtrvw9+GmnaJd67P421rTrcx/wBpagqwSXhBO3djIBxhc89MmvGZo/HH7SnjDUtI17wHe/DnwbpNrdWg1HVDG2o3V1LEY91tsLKIlDbt2SGIHpX0zRTk3KTlLrf8euhMUoxUY9D5w8N/sz/E2z8S6Je+JP2gNa8WaPp15Hdvo9zoNnAlwUOVBkjww57ivbvBvg+38DeGRpGnsXRZJ5wzcZklkaRj7fM5roaKG248ouVc3N1/r/M+K/EuofFf4rXvhjw74c8J+L/hl4h8PXrfa/EV/DYyabd7wRM6ea5aQMQWDIu4BiO9fWKeCbX/AITKz8SyPuvrXTW02NVXChGdXY/iUWprrwPod54mt/EM+npLrFuoWK6Z2JTAYDC52g4dxnH8Rrdpp2S76v71b8unmype832/4N/zPn34ifFPxn8HfiVrN2PhT4i8f6FqkVuLLUPCqxzzwbFIeGWJmUqoYswbPO+vOrH9knXfjd48b4k+Kte8Q/DSOa8kvLLwno8kMVzZs0ccbyvdJk75RECyYIGfrX2PRUx93Xdjk29tP6/r/htDmPh78OtG+GPh5dH0VLkwb2lknvrqS5uJpD1eSRyWYn618l69D8CtQ+OHjjU/ix44TRvELXq2reGb/UJNLsngiAELlAyi6Zlw24k/e244r7brC17wH4Z8VXttea14d0nV7u15guL+xinki5z8rMpK8gdKLvnU/wCugacrieSePtL+Ivxos7CH4c+OPD/hn4dX0K79c05JLnU5o+jCHIESDgjdkn6V5Z4+/Zq8QfDy30vwv4Y+Lvi7w/4C1q6GlxaBp3h231KG1MqkyNNO37xUkcsSx6F/bNfZEUSQxrHGixxqNqqowAB2Ap9OPuyuu/3/ANdO3YLu1v6XmfKdx8M/Fv7Rvi7W/D3jXxtp0Xgfw5crZ3Phfw3bTo11L5avGbi4mVd4XKtiMFcgg5xXb/Cv9n/xx4K8eWviDxT8Y9U8fWdnazW1rpd7pFtarD5hX5vMi+Y4CAc9a91ooi+Xb+n1f9bfIT106f1p/W/UKKKKQBRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABXMeMvGVz4VksEtvDmra+bpypOmRKwhxjlyzDA6/lWt4iutRsdB1G40exTU9Vigd7WykmEKzyhSVQuRhQTgZ7Zr5w+P/wC0fq/gTQPDHh/UdGuNH8Xa5p76hd29hDLqCWpiKs8KyRLg5+b94xChVY88Ai1aX9df8tf+Ch2drr+v6ufT6sWUEjaSOh7UtcXr3xQ0vQ4dBmjmt7+11K7itZJobqPFusinbIRnld20cf3s1leFfGWuX3xg8S6Ldz6de+GXsLe/0e4spQ8i8lJ45Mf7W1gfRqe7t6/gr/kTdWvfs/vdvzPSaK+V/iZ+2xeeBNC+IGpWXgaTWU8PTILFotQTbeQCR4p5pMAtCI5InBBBJBU969T8A/tCaD4r8C+Bdd1V4PD1/wCK0T7PpdzdxmRHMbSYzkZG1CRxnkcc0o+8rry/Hb+vkVJcsuV76/hv+Z6feXkGn2s1zczJb28KF5JZGCqigZJJPQAUQ3kF0cQzRynar/IwPynODx2OD+VebeI/iR4M8cXGu+AZL63u57qxuoZ1aVfJKqkYdC2ev79ePZvSuM/Z7U2fi+GO3Hl6ddeCtGdLdXLJFJE08bBcnpyPyqoq+/lbz+L/ACCSaV+2/wB8Uvz/AAPWrrxpdW/jSHQU8NavPbuqs2rpEos48qxwWLZyNuDgdWHrXUV82+K/2jIZv2kdJ8EQ/aLKy0W/jj1C4ks5hDI01tJsLTkCJFDNGoGSWYngY59iuviZptr40tdALwMlzYTXsd6LqPy90bopjxnIP7wH8/SpWsU11v8Ahr+QSTjJp+X4nYUVy/hLxuPFfgWHxFFYSRSNFIzWKusjiSMsrRgrwx3KRkda8D0f9tmXWP2hPDPw+XwPd2mia5piahFrt1dKhTMXmNmPGNqn5Cd2d2Rimk3LkW//AA7/AEYvsufRf8D/ADPpi31ixvBmC8gmHnNb/u5Af3i53J1+8MHI68Vk+NvFlx4R06G5ttA1TxFJJIY/s+lRq7r8pO47iABkAfUivBZtH0/w/wCJJp9FWKEW/wAR7e9kNrNuWf7Xaqjs3JB5lbj2rqv2qvjX/wAKs8M6fo9rFeHVvExmsrWezsZrtoCIydwSIEliSoXJAyck4FS3aCl6ffaLt+Ni0k6nJ8/leST+5XPa7a6M1lFcSxtalkDtHKQDHkZwe2RSR6hay3klolzE93GiyvArguqMSFYjrgkHn2NfMXxwsrf4oeCvh/4outdnv/BNhbre+IPDmm6mbSW9ieNT5hKEM/lfMxhJG4Z7gCvQdNuvB+n/ABqtfENleacBqvhgRJfC6XHkwSqyjlumJgef7taONpNPu16WTf42/p6GSfuKS6pP72l+F7v+meyVXu9QtbBoFubmK3a4k8qISuF8x8E7Vz1OAePavLPA/wC1B4E8cWviu6h1H+zbPw6+Z7jUSsSzwFNy3MXOWiYBsHvjpyK4/Wvih4P+Pfw90fX7e1aOTRPFVmTp+qkQ3NvLHcohcoGyMpJvHsee4pJNyS9PubSv+JT0Tfr96Wx9Dwzx3ClonWRQSu5TkZBwR+BFSV5f8AFnsvCOu2dxI832LxDqsUbM25jH9qkdefowrz39mP8AbJt/2jviF458MR+FrzQv+EdlxFczSb/Oj3lP3gwPLfIzt5470l70uWPa/wAv6Y5JxTctk7fO7X6H0lRRRSEFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRWT4m1PUdJ03ztL0ptXumkVPK89IVjBODI7OR8q9Tty2OgJ4pDNais3QdRk1DQdPvLp7MzTwo7tYzGW3LMB/q3IUsvoSBn0rjP+FqXlhqXh6z1TQ3sX1rWp9Kiy5zEiRSSRyOCo5fy+AMj5hzVWd+UXS/9bXPRaKK4n4ueLtU8G+B7zWNDWxnvLSeASJfM3lCMyoJNxXlTsYnOOOuDSA7aiuW8E+OU8ZXXiW3W1NtLomptpsil928iKOQP7AiQU/wx4h1fWNW1CDU9MttHjhRWhtWvVmvMF3XfIiZRUbZlcMSeQQCMU7beav8AfqHfy0/Q6aisrxReavYaDd3GhafDquqRruhsp7jyFmORld+CFOM4zxnGcVzlv8T4pNc0LR7nT5dP1XUJGiuLK4dfMtWELyj7uVdT5bgMpI+U80lrogemp1HiCxvNU0PULPT9QbSb6eB44L9Ilka3cghZAjcMQecHg4qp4d0G70/wjY6Prmpt4ku47UW95qFxAsRvG24Z2RflXdzwOOa268h1z4zaj4T+ImsaNqVjaz6VHdaRBaTQuyzJ9skeItICMEB04I9ce9CXM+Tvb/L9f89gbsubtqcHon7DHw88KfFax8QaF4E8L6fpVs3mh914175hVwxXMvlgZK8YPGfauv8ADn7LPhP4P2Or3Xwe0yw8B+JL5AGunSW7t58ZISWN5MlcnPylSDjr0PtdFGystB7u7Plb4Y/sI+FW8Qap42+K2heG/FPjzU7z7ZKdLtpodOgbnJSF3O4tnLFxjOOO57CD9hL4CW8WqRp8M9I26kNtzuaZiRu3fKS+Y+f7mPTpXeN8ShpHjzxHpOvSafpmkWNvYzWl48zB5DcPJHtcEbR88eBgnO4cV0Vx4kmXxFFpVvo9/dL8rXF95Yjt4VZWIIdyPMOVwVTcRuBIAOadrpWWgapu713/AF/4Y8m1z9hv4E+ItP0qxv8A4a6TJbaXAbe1WNpYisZOcMyOC/JPLEnnrXqnhHwB4f8AAen2dloOlxadbWdnHYQJGWYpbxklIwWJOAWPU96brfi6TTdXtNMs9H1DVLi4wzTQRhbeFN4VmaZyE3DOfLBLkZwDXmvgP4teLNe1TwbDqdrpEVvqd3q9hemFpA4ktZWWMx5HUiNiVP1B4wWm3t1/r+v+HJdlv/X9WPTfHXgPQPiZ4Vv/AA14o0uHWdDvlCXFncZ2yAEEcgggggHIOeK+U9U/4J5+BrW08RTWPwv8D38qoTo1lJdahFuYOeJ5PNPVOOB94Z6V9l1R1vV49B0u4v5oLq4jhXc0dnbvPKecfKiAsfwFZ2V7lqT0R4R4m+BvxCsfBugeDvhl4p0r4eeEfJS31CyW2kuLqxjIzItlOW7kn/WDPJIYdBLa/sF/AiHw3/Ys/wAPdPvoGlW4muLmWZriaYLgu0u/dzySAQuTnFemy+L9Sh+Kun+HmhtP7Hv9IlvopmZxciaORFZduNpXbKh6ggjoa7Oreq5n1/z/AM1+pK920U9rem33bHnfw2/Z7+Hnwh0aTSfCHhe10bTpLxdQa3jkkkU3CjCyfOzcgCvQ+vB6V5r8RPiRrHgjxnYW0NhbXuiyaJqOoyqWZbgzW4jZUQ/dO4OeD6Z7V3PhvWo/Enh7TNWhG2K+to7lFznAdQwGfxou5K/9dV/7b9yBrla8/wDh3+f3niGrfsC/ADXNVu9Svfhrp0t5dzNPNItxcIGdjljtWQAcnoABUNv/AME+P2ebW4jmj+GOm+ZG4dd1zcsMg5GQZcH6GvZvEnjnTPCMd/NqourWysbCTUri+NrIbaOJPvAygbd+Odmckdqzfh3411fx3BJqc/h2TQtCmRXsJLy4Rrm5U8iQxpkIpGCAzbueQKUdPh6f1+n4Dk29Zdf6/X8Thbj9in4G3XiiLxDJ8NNEOpxuHVljdYcjp+5DeWfoVqvD+w18CrXxPB4hg+HOm2+r29yt3FcQzToI5VYMrKgkCjBAOMY9q91rifi94s1fwT4QTVdGhtLi4W/s4JEvCwj8qW4SNzleQQHznnpTjo1bTX82HxXR1em6TZ6PFLHZW6W6SzPO4QfekdizMfckk1Dpnh3StFur250/TLOwuL6Tzbqa1t0je4f+9IVALH3OTWT4G8bJ40XW9ts1pJpepz6bIjNuLGMjD+wYEEexrp6XRPuvweou68/xQUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABXE/FvwT4g8feGF0nw94sPhCWSYG5ulsRdGaHB3Q43oVDZGWBzjpjrXbUUmk9GNNrVHyr4mm8V+Bfg/ZfD++8HXVxNprw2mla5HrdhbQztHOPsrqstwJAeIwVK9cjkc109j4J8WeMviNJ4kvvC114StY9R029EGpX9tcF3hWdJpFEMrhco8a++Ole7SaLp82qwanJYW0mpQRtDFeNCpmjjYgsivjIUkDIBwcCrjKHUqwDKRggjg1fM78z1d7/ADun+mpNlZxWzVjx/wCNHxM8WeBfG3gC00O10280jWr8WVzHPIv2mR2I2iMFwQoXexZVfGBkAc1598QNO+IfipfFa6d8JNWsP+Ei0Z7K7Vtb03ymvAVEM+BP0Vd4LYDEbeOOPbdL+DPg3R/GreLrfRlbxF5Zijvbi4mnMCEYKwrI7LCCOojC5rtaUfdSfXX8en9fpcq/vXW2n4O/9f0jgfhz4N1Lw3q3jS+uvLt21u+ivIlXD7GFpDExODz80Z9OnvXm/h34f/EX4P8AjnUPE80118XJ9btvs121qtvps1v5cheHCTTiMoBJIvykH7uQeTX0NRRd35vK3ytYX2eV/wBWPn7S/FHx00/x7canqvgf+0fDVxbv5ekabqdkHtuU8oF5JE3Sj95v5KYK7Txzh6x4U+LvjD4haL8SNU8Pw2Fv4auP+JX4Jsr+3a6ukkV4ppZ7gsIt4RyUQPtHOTk19O0ULSzXT+vn21G9brv/AF/Vj591bxt8a7y31uC2+F99ClzexSWUh1vTleG02oJo2xLxISshUjI+cZIxWDb/AA98fePL6GbWfCd14fuYrDRoZ73UdQtbhrmezvFmZwIZWONpkPzYJr6gopxlytNdLfgrL/P11Bt/16p/oNLBcAkAnpk9a8f+EfxN8WeKPFvxI0fXrGxmbw/dolkulyIwdXDssTP5hG/aqE7thBflQME+neIvDWn+K9Ll0/UopJLeQFSYZ5IJFyMHbJGyupx3Ug1R8CfDzw58M9DGj+GNKh0nT/MaZo4izNJI33nd2JZ2PdmJJ9aldb9v8hPZW7ngviCb4u+IvH2p6tD4E8SeGdLn0+KyT+x9V0d72Rkd3Dl5ZmSMZcjaFbI7iuc01vj8uo+CNY8Q+DdYvLzQ2ZdQaHxBp9vDcQ7pMuyLOEkdozGCHVQrISpHSvr+q9/YW2qWU9ne20N5aToY5re4QPHIpGCrKeCCOxoXu2t0/wCD/mU3zXv1/wCG/Q+V7XUPGHivSfFkejfDnV723uPE0OqWklr4i0xhZzQmBpYyRccHzI5CVGR89bXhHw/4/uPGHh0Xfw7vtC06y8U3ustfXWq2Mqx21xDKGQrFKzF/MlzwCMd6+kLW1gsLWG2toY7e2hQRxwxKFRFAwFUDgADsKmqovlat0Vvy/wAkS25Jp9f+D/m/nqZB8T2X/CRXGjK++8trRbydVI/dxsxVMjqdxR8YH8J9q8gtf2gP+Fq2Ot2HhLwPf+MdLVDbXFxYaxp0RAkQ4DxyXCyRkjPDKDxXbfE/4N6P8SES6ZFsNdiCpFqsT3EcixhslGME0LsuC2AXwCc4rc8CeBrHwLosVnbKJboogubxmleS4ZRjcWleR8dcBnbGetRyqUWpf1/SKvytOP8AX9M+c7ez+MTP4Hib4f61p0eg6LJpt3qNrqulTX1xI6xAmNpJ9qD90DuYMT/d716p8F5PiPY+CfEaeMoJv7UhvJ20VdYurWS5ktdimL7Q9t+7zv3AlQOAK9crmvHHw50D4jaW2n6/Zy3Vq42usF3NbM691ZonVip7qTg+lVKUpKXd3/F3ugVtL7L+reh88/D7xb47+PEvhm+1HwiBBpl5qlhf6/Bd2gs5ozDJEVjjSd3P7zYuRlTtJz2H0H8M9BuvB3w38NaPqUkZvNO06C2ndT8u9ECnBz0yK2NB0DTfC2jWek6RZQabplnGIbe1t0CRxoOgAFWrq1hvreSC5hSeCQbXjkUMrD0INU5JJqPW34X/AM2Z2u+Z+f4/8Mjxz9ozxFHY3Hg3SrW3ufEGralqRgPhe0lhH9p2jQyCdZVlYJ5YXncxADBeeazfgN4e8SfD/wAR3GhW3gvVPCfw6e28y1s9X1W0uxYXIYDyrfy5pH8pwSdrcKV4OGwPTPCvwk8J+C/EGoa7pWkLHrV+Ns+oXE8tzOVznYrysxRM/wACkL7V0upaXa6xaPbXkCzwt/C3Y9iD1BHYjkVMfdV1q3/X4brzLl72nRf8Pf8AT0PIPif4+v8Aw/8AGDwvZeGLbUPFOtNYXZvvDdhdwxRi3+TZPKZWVUIfAHOSGbAOK8/14fHnW9K8X6Pr3ggazDq1ujae+m6nZJb2FwJCygGSRJGQKI8kgncrEcEV794F+Fvhf4bLfHw9pK2U19J5t3dSSyXFxcN2Mk0rM7Y7AsQO1dXSj7tuv9f15+mwPW/9f1/l95w3w38H3/hbUvGFzeeWser6ot9BGhztBtoUbPJ/jR6ueFrrx1NrF2viTTfD1ppQB+zy6XqE887HPG9HgRVGPRjzXW0U77eSS+5WJSsred/1CiiikMKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAx/FfjDRPAujyat4g1S10fTY2VGuryQRxhmOACT6mvOPhz+0r4J8ca/qekR+MNCur46m1pptva3A8y4i8tGUgZ+Y7mcZHpXr9YXhnwuPDdxrkouTcf2nqDXxBTb5eY0Tb15+5nPvRH4nzbW/Vf8EmV7Ll7/AKP/AIB454LsPGPhH9or7N4iv7e8tNdsNQuIpbfUriQSiOeEwhraRRHCY45Cn7sndyWrpdU0G78IfFjwxcR+L/EFxYa5qFyH0W7uIXskb7NI+E/dCQDK5ClyBzxXf6x4O0/W/EWha3P5yX+jvK1s8T7QRJGUdXGOVIIOPVQe1J4q8F6b4w/spr9ZRLpd9HqFpNBIUeOVM9/QgspHcMRVRduXy0+V/wCvuKl71/PX5/1+BwPxQ0G70DxDpPia28X+ILCC61fT7SfR4riH7BIGmWM5Voi67gcHa4B9K9brD8aeDdN8feHLrRNVSRrScq26FykkbqwZHRh0ZWAIPqKzdY+Ffh/XvElpr16NTbUrXy/LaHWLyCH5Dld0Mcqxtz1ypz3zSjouV9/wsv8AL8RPfm8v6/ryOR1S88T+Gf2k9HzfyXng3xLpMlr9icfLZXlvmRXX/rojOD/uCj4sXnifwv8AFD4ca9pl/JJ4buLx9E1fS8fIRcAeVcf7ySIq/RzXpmoaHa6lqOm306sZ9PkeWAjHDMjIc/gxo1rQ7XXobeK7VmW3uYrpNuOHjYMp/MCiOjh5P8L6/g2l8gldqXmvxtZfirmhXzP4X0fxlpP7XevaF4g8Ya5f+Eb2x/4SPQrCN40t0ZZFjmgkOzeyoXRgocDkZBr2vW/hb4f8Q+J7XxBerqR1K2KGM2+sXkEPyHK5hjlWNueu5Tnvmti48M2N14mstedD/aNnbS2kTjGPLkZGYHj1jWiNlJTfn+Wn42fyHLWLj3t+f+V18znfHnxg8P8Aw48TeEdD1l7lLzxRetYWBhgaRfNC5+cj7oOQM+9RfEH4hXfh7VLPRNDi0q71+4ga8Fvq1+bOMwIyq21gjEvlhgYxwckV2t1Y218YTcW8VwYXEsfmoG2OOjLnoR6isrxJ4F8NeMntX8QeHtK1x7Vt1u2pWUVwYT6pvU7Tx2qdfx/Dp+P3rsHp2/H/AIb+nsJ4H8VDxt4T03WxY3Gmm8i3taXOPMiYEgqSCQeQeRwRzXOatdaj4f8AEepWCahK6a8qvp/mHcbWYFY5Qv8As7SsgX1D1p+MPhb4e8cyWT6rHqANmpSFdP1a7sVA44KwSoG6D7wOK19Q8MWGqX2j3dxGzT6TK01q24/KxjaM59flY/jiq0bv/Vg6W/q55x8YfCtzo+lf8JNY+MfEei/YYba2ltLO6iNtPGsoG6USRO2cO2WVlJGOeK6n4keEZ/E2kxXVp4m13w1c6fHJKs2iTRIZQU+66yxyKw4HbI7Gug8T+G7Dxh4d1HRNVh+0adqED21xHkgsjDBwR0PvVjTdNj03SbbT1eSeGCFYA9w293ULjLHuSOpqJJyi1fXoNO0kzxjxzpni74gfsrW0vg3xPeaX4ubSLbUbPVIyrSTzIiybWOMHzCCDxjnpXSfs23VxrHwb8N67fanqmralrVpFf3c+rSK0omZFDIAiqqqpGAFUevJJNdl4N8G6d4F8OQ6FpYlXTYGkMMU0hfy1dy2wE/wruwB2AAq14b8P2fhXRbbStPQx2duCsSHHygknHA6c1tKS5ptLSTv6b/np9xCXuxT6fj/X6sbNrM9rq1xDcafJb6XDa/aG1aSaIQ7snMe3dvBAG7JXbjvmna14k07w/Z211f3KwW9zcRW0UmCQ0krBYxx6sQM+9c78RNJ8TeItH1rTNMg037LNZA27z3DiSWcPlonXZtWNlGN24n5j8tcdr0vxA+KWkxeHm8H3PgK3eaB7nWbvUbS4khWN1cm1SJpMyZQBTIFAznBxis1q0v63/r/gl/1+H9f8Aq/Hb4tarY6G1p4Jj1HULq2vIk1yTRbQXF/YWLPLG88ET8SMJIiOA2ACdp4qx4E1GwtvGXhOXQvEmoa74c1XQL25NxfXRn86SOaA+Y2cbXHmMCAABjGBinaT+zUug311eab8SvHNlcXRLTut1ZSeYxYuzHfatglmZsDAyTgCrGm/s32Wj2r/AGLxr4rttTe+mvjq0c1oLjMqqJYwv2bygjFFYgJksM5yTTj7uvX/ADVrenX+tHLllp0/p39b6en49F8JPizpfxX03VLiwu7WebT717aWO1Mvyr96JiJEQ/MhVsgFTngkc1yuvftQaD4fuLq9l0bVpvB9lqX9kXviuFYjZ2t0H8sqy7/NKByFMgQqCetdF8J/gjovwhm1mbS7y8vZ9WdHuZLqK1iyU3YIW3hiXPzHJIJPrXmt1+zb4hbwr4h+HMN9pT/DzXNUk1Ke9mkl/tKFJbgTyQLGE8tssCBIXBAb7pxTVudLpZffpf8AC/8AWjno79/w1/4H9ar6MR1kRXUhlYZBHQinVHbwrbQRwoMJGoRfoBgVJS9BK9tQooopDCiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAqCS9gjjncyqRACZNpyVwM8ge1effEL4lWPgDxdpsfia9/sbwld2E6PqU2Utxc74wiPKPuEoXxyM/hXn+pfGD4X6B4XfT/AIeeNPDsOtz3NufLhulubnUCHVSjsxLyuyZXcxLe9Ldaf1rbUei3PePD+vWPijRLLV9MnFzp95Es0EwBG5T0ODyPxq+zBVLMQqgZJPQV89+Hv2gvCPwx8Ay6LcXv9o+K9LuLqD/hGbFTJfswuJCo8oDIXYVYtjAXmvSPg/8AEqy+NXw9i1wWcccU0k9pcW+7zoWZHKNtYgb0Ycg46HkVVr3cRbW5tDR/4SS9f4iQaYtzYLpEmnG4jTerXE8m8DcvzZCKOPunJbqMclr8VPC959oEWqxl7fVRokqMjBlvCQBEQR1OQc9MGuLsPElgvw98Uwa+ul+GoPC2ozWNtcWCqkEARUe3eJf4WCyIu0fxAgcHFcDo9rqnij9n3w3rU7/bvEFz4rtNTu/s8RjCzLqKpIqqTwFVMdexpxXNJLpp/wCTNW/8lv8Ah6BK9tN9V9yf62/E+nqK8d/aM8baX4F0/QrrV728jtLi4eL7DDfmyiuiqGQK0qrv3/JhFDqGZsNkV6bbapPq/heLUbOFrO5ubMTww3yENEzJuVZADwQSARn1qL+65dg+0o9x9l4i07UNa1HSbe5WXUNPWNrqEA5jEgJTP1Cn8qJvEWnQeIrbQ3uVXVbi2ku4rfB3NEjKrt9AXUfjXg3gX4hQaT4o1/xz4smh0DTdT0HSkvLtW3WsN0s1zE2H/ukkYY9sZqP4eeLD49+KHhXVLLVo/FcGlSaro767Zovl3EDRwTI7FflyDsQ44LKTgdK0Udbff/Xrb5MH7qu/L8Vf/gep9H1ha14xsdB8RaFo1zHdG61l5Y7Z4YGeMNGhdg7AYT5QcE9cVzWofGrR9N+MenfDma0vF1W+tGuoboqogbAZtoy25jhGyQpA4BIJFea/H34++CPD/i7wnpq63p15r+m6s7XFm18tv9lQ28sbtLKSBHjzBxncf4QTWfbz/wCG/Mdt12X6XX3nvuta9p3hvT5b7Vb630+ziUs89xIEVQOpyakvtWstLsHvby7htbNF3tPM4VAuM5yfavjDU/2vtG0nw3qWmWreE4de8LzxNpuptqE2tW8kMkTlngkkVJpJOPKbbkjzAfmHFehal+0l4B8TeKdGS/8AGfheTRLnRWvfLvGilGnanG8RicMwOHxI+AcEeXxTfl/Wl/8Ageug7apP+tbf8H02PSNV/aE8O6Y2tFLTU9Qg0tLCZ7ixtjNHNDdttiliIPzgHOQOeOAa7fxL4u0rwjp8V5qt0LZJnEMEe0tJPKQSscaAbnc4OFAya+Mtc+O3hbWPDvii5vPGejXHiDVfBlqHe3mA83ULaWUhVXHDsZAQvWvp74oeJPG1t4GsZPAnhttf1TUFVHkN1DB9ijaPPnbZXQSEHHygj605e7Dmjrr+tv03+Yl8Vn/Wif4X+eyPQbG8XULG3ukjmiSaNZBHPG0cigjOGRgCp9QRkVX0fXtO8QR3Emm3sN8lvO9tM0DhgkqHDIcdCD1FfPkP7RGn2vwz8M6afGOm2nxEs5bG21PSbmRZLqWVJUjuYinLbmAfB9wa0br9p7wXbeOpbVPiPoo0fUdOldRcSokmmXcZRQp4B+cOx2vyDGfXAJWTfLqtfw1v8+nmKKbSvvoe+PcwxyFHlRXC7yrMAdo7/SsnVvGej6PJFBNfwNe3EbyW1mkqma42IXIRc8naCa+UPDv7WHh278deErbxNrHhG6tb7SG07U9UaBWm3+W7uzy52xRFkVfKccmQEHitPwn+0F4I0fT/AA1PH4w8H2N42qz6XrJto4YWu9PjNxHbOSqgqqgRMP4cNxwaUou2j/q7X+Q13a2/yv8Ao/6Z9EfD/wCKWhfEmwtZ9KlmSeewg1I2d1EY5ooZtwjLKemSjflXX181/sxlNQ16y1XTybrS5fD7aet3GB5TrbX86REHuCjEj2rprz4jaXpH7Q8Xh2WXUtW1S4CRw2/24gWSyRlmYWyqqvDiNcyMXYM5AwKt2ckkrXv+Da/Qm6962yt+Sb/M9sZgilmOFUZJqh4f8QWHinR7XVdLuFu7C6XfDMoOHGcZGfpXP/FDxRqPg/RdP1GxhtriFtStbW8iuGKkwzSrESh/vAurYPXBHevHNH+ImmfC/wCDqaJqniu18F6/DcX8umHVAqpcRx3kuxQG4ZWUKCAcgMDxWd9HJ7f0/wAv1Ks9Euv9f18j2WD4r+GZ9M8S3wvnji8ONKuqRy28iS2/lgliYyu4qQMggEMORmtHwr450Pxsty2i36X6W/leY0YIGJI1kQjI5BRlORXif7RXjCHUPhr4evdO1VNI1vXoY4fIZN7yWE4UXJKZziNG3huzKo/iwejm8e+FPhJ8TNdt/EmvWPh631DTrF7KTUJViE5QSxvtJ4JUBMjtketXy8t+bdafNb/169ieZSUXHrr8nt+v4Hs9cj8RPiZpnwyt9JuNVt76a21C9FkJbO3MwgJR33yAchMIckA4zXKeA/is83wR1DxjqN/b6vHYNflL+DCRXUUM8iRyDsAyqpz05zTvja0snw40S5uJIZb5dV0w5hGFkZ7iONtg56h2454qZRknZb3S+9lrdr1+9f8ABPTdL1S21rTLTULKUT2d1Es0Mq9HRgCp/EGrVfOfhP8AaZ8A/DjwD4N0TVfEenLqlqINK1KzE376wZUKM0iAEqquoBJwADmrPiv9sjwWq3tv4T8ReGdSvLRSzy6xqpsrZiOdkbCN2kYjoVUr2Jpz5U3yu6JUZaKW57B4k+IWgeFfPjv9QT7XDbyXZsrdTNctFHjeyxICzY3DOB3p+n+PtA1ax0S9stThurTWn8uwmhJZZm8tpMD0O1GPPpXgPg79qPwLrl94R8SafrWg+HYtbhmm8S6W5jW4hlEQ8uWdwA2VKeWC3USD2rC8efGbTvFPxQ8PeIPB1jNL4I8O6jDd+JfFrIyae+7dAqxZXEjL5pLyLwqjBJ7O1pKMv+G1/Lz/AM7IunFyXS/z00Xr5H0v4R8dWXjK81+1tba8tptFv2065F1CUDOFVtyHoylWU5HrXSV438DvGGh+LPHXxNuPDusW2t6XNqFrdpcWUgkiDNaxoyhhwTmLn615P4g+L3jy6+Gfij4taX4gmt20DxDNp8fhJreI2dzaxXQgKPlPN85gdwYOADgbTSW8Y+Sv+Cf4v7h2ve3ey/F2+5fefXlFRWsxuLWGVkMbSIrFT1GRnFS0baEp3V0FFFFIYUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUV5T+05rfjzwv8AB7WNe+HT2v8AwkOk7b4295B5qXEEZ3SxhcjkqDjkfUVzupeJviJd/stzeL/C+tWeueNLvTo9atWk08Q25UoshgSHex+6GA3OSSTyO08y5ZSf2f1/p/cylFuUY/zfp/w6+894oryv4Hy+L/Emg6Z4t13xhBrWm6xp8V5BptvowsvszyIrEFvNcsF5AB5yTknjE3wh+Lln8UNY8UwiW6sNS0e8azn0G+tjDNbKrMElORlhIBuDA4xjvWsouMnB7r9DNO8ebp/menUVzln8Q/Dl944v/B0Gr20niextY7240zd++SFyQsmO4yMcdOPWtfWIryfSb2PTpkt794XW3mkXcqSFTtJHcA4rOTtHmsWt7Fyivnz9kvxr8RPiBo3iCf4havZnXdCv59CuNLsdPEEayxlT57OXYvvUqRgIACeD2o/BzVPi/wCOvEXifT/EvjDT9Fm8M65JZT2FroQc3lm2JIZFmaXhmQgBgmBg5BPNXy6pX6X+Wn+aJeibfR2+ev8Akz6Ror5x03WPi94j+OHjnwfL4s03w1p2nGDU9GkGhfazdWUo2sjOZkAKMCOBnJByRxXefEL4r2vgPxp4M8K6nc3mmw62Sg157bdA8yFQtuzgbUkkJ4yMcHFTH3lF/wA239fh66Dejku2/wDXpr6HqVFFfOOieMPie/7Vmt+BNb1yxsvCJtV1/R2t9N3T3VurLHJbGYuAm1+T8jEhuCKI+9JQ73/DX8rv5A9IuXb9dPzPo6ivnvxx4g+Ksn7RKeDtM8Raf4c8K6xo5vdKv5NH+2yC6hb99C2ZUABVg3OcgEDHWvTdZ8W3/gXR9PsGtL3xv4kMJlkt9NSGCWZFIEkwWSRVVQWGF3E8gDcaPsqXf/Nr9P12D7Tiv60T/U7eivLvG3xz07Qfg/8A8J5p1pqF/prukbGGzd5bUGXy5JJIgN2IiGLD/ZNd34T1W01zwzpmoWOpDWLO6t0miv1xidWGQ4wAOadnr5B28zWor59/ap8dfEf4a33gnWPCOoadZ+GbrUk0nXHvbE3RthO6rFcKodCQp4xu/iGat/tEeJviL8NPC/gq/wDDOrWs1vHqVvY+IdQvtP8APbyZcR/aBErp91yGIDDGe4FJe8k11dvnp/mvv9Rv3d+1/lr/AJM93orhdGbW/h54burjxd4lHiu8aZY7ZrbT0sixY7Y4gm9gzsxA3FgDxwK5zXviR4k8YfDnxrb+EdMuPDfxG0i03x6XrcaP5cjKzRHdGzRurhGwVYjPBpSainLsEU5NLueu0V45+z9qHjjxx4Z0Pxn4i8W297Y6pYrO2iW+iCzNtcEbXUyGV2KqQwwRnIznHFdB8frnxtp/wm1+++HkttH4rsohd2qXcXmRzCMhnix6soKj606n7q/N03FT/eNKPU9Dorwfwj4q+IPjb9l2bxfo2tWWpeN9X0s6jp6mwFvbW8uwf6OIy7E4ZWGWY5J7dK0fgFqnjbxl4V0Xxv4l8X2t1p2paeLiTRYNFFn9lnxtdTIZXYqpDDBGcjOccVbi4ylF/Z3/AB/yZKkpRjJdf+B/mez0jKGUqehGPSuA0P4v2ur+KbTR59G1LTINUVn0fVLhY2ttSVU3sYyjsUO0FgJApIGRmszw7ceMtA+KtvoOu+K7LXtKvLC8vraGPSPss8YSaMKryiVg+Flxwi525NSo3du5fe3Q9C0DQbPwzpcen2P2j7NGzMv2m5luHyzFjl5GZjyT1PHQcVo1FdLK9tKsDiOYoQjsMgNjgn8a+e/2WvGXxL8Y6r4x0/4i61YtqvhW/fSX0+w04QrOCFeK6aQud25OiqqgZOc0l7za7K/6fqvvE9Fzedv1/Rn0TXJeOvDPibXrOSPw34t/4RmeYBJJpNPS82LzkxAsm1zn7zbhwPlrxv4S6p8YPHHivxbpXiHxhp+hyeGdba1ezttCEhvLGQeZDIJmlGGKHaGCYG05DGu817xx4l8MftBeHNCuo4Z/BniTTpobWRFxLbahCDKQx7q8WcehSjl5uXz1/C/9eeg78vN5f52/Df01Nvwv8F/CvhvwGPCVxp0XiHTJJWubw65Gt417cM255pt4IZy3PTAwMYwK67SdHsNA02DT9MsrfTrC3XZDa2kSxRRr6KqgAD6CuY1bX9T8N+JL5Ll0udNvLTzdPXaFZLhOGhz/ABbwQw9Nre1aq6pPpS6Vpd411dapeROPtsNjI9ukiruZpGUbY1z0DEZ6A5p3b1/r+l/WgrdP67m9XnfxF+HHiTxzCdNs/HN1oGg3RYX8NpZobyWM8GOK43DyVIyM7GbngisCPV5fE/g34kaPa+MbnWfENhbtBc3lmiW0VnO0G5RbhMsg6H5nc7s89q6r4e+N7C88N+CbG71OS61jVtFivomuB+8uQscZkckALuy4JHHU8UuVSv5W+d7v9B3cbW8/la3+Z03hrw5p3hDw/p+iaTbLZ6Zp8CW9vApJCIowBk8n6mqF74WurvxUdXXWLiGIWRtI7RM7Y2LbjIBu2ljhR8ynAXgjJroJJEhjZ5GVEUZLMcAD61n6xdag2izTaFHZXt+VzAt5O0cDnP8AE6K5Axnoppttvme4o6KyOF8P/CfWP+FjDxh4r8XSeI57OOSHSdNt7IWdnYq/Dvs3uZJSvy7yehOAM16ZXOfD/Xh4k8MxXv8Aa1rrT+dNDJdWds1vHvSVkZNjMxBUqVOTzjPGcVY8XeKLbwpoOoX8skBltbaS4WCWYRmTapOMn1xSk+SOuy/4ccU5S03f/DG3WBonhCLR9XvdUk1PUtTvbksu69ucpFGWLCNIkCxgKScMVL44LGszxF4i1bV/h1e3vhBLa+8RSWQltrZbhCBIyg43EhcjJxuwCRzXIfBnWPFPi7wB4o0rU7/U9L8Q6dqFxpsV9qyWs95ATGjxvIID5LlfM/hwCAM85p2d5Lql+tv1J5k1F30k/wBL6nsNFee/DG+8TvqvifSfE2vWWu3WnSwpHcWOmmxUK8e7lDLJk89d2OOlUfCc3jHQ/iYmgeIfFVl4hsJ9NnvLdIdJ+yTJtmjVfMcSuHID44VPXFC96SS6/wCVwbsrv+tbHZax4Rj13WrO+utT1Jbe12smnW9z5Nu0isGWRtgDsR02l9hB5U1Y8SaAfElgtp/ad9pkfmK0jafIsbyoOsZYqSFYcErtb0YGtVs7Tjg44ry34C+OPEniiz8VaP4viiXxH4c1qbT5prddsVxCQJYJFHvHIo+qmktfd7a/iv8ANfLyK1XvfL8/69T0rTdPh0rT7ezt/M8i3jWJPNlaV9oGBl2JZj7kkmrNeV/Dfxx4lufiz8QfB3iaKJl094NS0e7gTasljMCoRv8AbR43BPuK9F16G/udD1CLS50tdTkt5FtZ5V3LHKVOxiO4BxSk3y8+91f+vPp6go+9ybW/r7ra+hfqO4iM9vJGsrws6lRJHjcue4yCM/UV4N+yT448ffETw7rV78QdUszrmj6hPod1pNhp/wBnjhmhYZlLl2MhdSpGAowehr1vSPiF4c17xZrXhiw1e2ufEGjCNr/T0f8AewLIoZCw9CCOapx2XdX+W/5Ep76bO36fnocff/BrUfFfjXT9W8W+K5dc0TSZ0utM0C3sxawLOv3Zrhg7Gd1PK8IoPO016lXzb4J1X4weMPif498L6p4w07w6nh/Ukns1g0ITteabcBzEfMaUAMu1lzt4ZOd3SvXvF3ia+0PxV4Yt4pFGlzTNHqLFQSN42Q89syEChX5Yrv8Aqvz6d9LDlpKXl+n6dfn5kfiT4a2Xiz4gaRreradpOp2Om27Lbx3llDNNHOWDCRWeNmGNoxtZcEknPGOxvrKLUrG4tJ9/kzxtG/lyNG20jBwykMp9wQRXgn7UPjr4kfDrxB4C1DwpqOnWXhbUtSTRtZlvNPN21q87qsM4UOmQDlfvYyw4NT/tTeK/iP8ACf4Q6f4l8Faha31zoc0T62+o2YmNza42SSBFK8qSHIBHAPNStYeV7fP/AC1Xy9CrPnst7X/rz0fz9T2ttAsJdBOjT24u9Ma3+yvb3bGYSR7dpVy5JbI6liSe9cd4e+Angfwvq9rqdlpVxJdWhzai+1O6vIrY+sUU0rpGR0BVRgcCub+Kl18RtD/Z5vdV8Ga1aa141tLddSS6urIJFdoG8141hBO0FMqo3E9PmzzXQ/AHxDq3jT4V6F4n1nWI9Xu9cto9QBt7P7LFbq6L+5RNzn5TnJZiSc9Og0s+aT6r9dv1+4zuuWPZ/wDA/wCAeiUVh6p4wsNHvrm2vEvIRb263L3JtJPs5DNtCLLt2tJn+AHdyOOa2XYmJirBDtyGYcD3IqOlyutiHUreW80+5ghuGtJpY2RLhACY2IwGAPUjrVXw3o7eH9CstOa5e8a2jEfnyFiz47kszEn6k15db/F6XV/CtzeaX4o0WS30e4a11vXbnT7iIQuGXY0Vrn50cNjf5oUD5gW6VpeGfixaeG/hPdeJ/G+rxQ2+n31zZ3OoeUQp2XTwo21RxnC9KOjfp/wPzHrdK39f0j1KuHuPgn4Lu/FTeIZdEU6k8y3Mii5mFtJMpysr24fyWkBAO9kLZAOeK7Cw1C21SxgvLOeO6tLhBJFNCwZHUjIYEdQRVinrF36ondeQUUUUhhRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQBBe2sd9Zz20ozFNG0bD1BGD/Osfwt4RtvCvgyx8NwPvs7S2+yRkrj5ACAMZ7Dj8K36KXddx3ehk+E/DsPhPw3p+j27mSCyiEKNtC8Dpx2rl/h98O9Z8EeIvEV3c+J11zS9UuGuo4LmwC3cLseFa4D4dFHyquwYHeu+oqutxdLGDD4F8P23jKfxZDpFrF4kuLUWU2pJHiaSEMGCMR1AIGM1Q8P+B7/Q/EV1qc/jTxBrNvNv26XqBtfs0O45Gzy4EfjoMueOua62ilsG5z/h3wbaeGdZ8Q6hat82tXS3c6bcYkEaoTnPOQq/lUmk+FYNI8Ta5rMUhMurCASx7QApiVgDnvkN+lblFH/DA9dWYf8AwisH/CaDxIJCLn7A1gY9owVMivkn2K/rXO/ET4d6z4s8QeHNY0fxMuizaPK7mzu7AXlrcbgBuZN6ESKM7XDcZPFd9RQtLeX+d/1Dv5/8Mclr3gbUNa8RWuqQ+NPEGkQQhA2l2H2UWs205O7zIHk+bocOOnGKu33g60vvGmleJS22+0+2mtF+XO6OUqSM545RTXQUUAYereFYNW8SaFrLyFJ9JaYxqFB3iSMoQT265/Cszxp8KPDPxA1Cw1DWbO5a/sVZLe7sdQuLKVUYgsheCRCykgHaSRwOK6+ijt5B38zjfHfw7/4Sj4f3XhfSNTl8MLIqiK5s4w+zDBirKSNytyGGQSCeec1Hc+Bdc1TwfpelXPjK+0jUrTHm6l4atILQTAAgKIpknVFxjgHqOuOK7aijv5h28jk/Efw/i8UeAZPDGo6jc34eNEOoXao0zOrBlkYIEUtkA8ACtDxp4Vg8beGb7RbmQxRXShTIFDFSCCCAe+RW5RTv1Fyq1jD8ZeCtG+IGgy6Pr1n9t0+R0kKLK8Tq6MGR1dGVlYEAhlIIxSeFfBWkeDNNay0qCZI24eW6uZbqZ+uN8srM7YycZY4zxW7RS6NdxnM6L4ITQfBT+HbHUrqxXE/l31qqLNCZJHfKBlZcqX4yCOOlSeD/AAndeF9PuLW98S6x4oaZ93n6ybfzEGMbV8mKMY+oJ966Kije9+oLRJLoYHgnwhbeB/C9todq/mWtu0pjyuMK8jPtxntux+FL4V8IWnhfwumhIftFmpmyHUAFZJHcrj0+cj8K3qKHre/USSVrdDi/BPwe8KfDuXfoWn3FvtGIo7i/uLqO3HIxCksjLEMEjCBRjjpV3xB4ITW/FvhzxDFfTWN5o7TArGoK3MMibWifPbIVgR3UV09FO7umPv5nJ6b4Hv7DxZNrMnjPxBfWsjORotybX7Gm4cBdsAkwO2ZD75q7o/g+20XxXr+uQP8AvtYW3E0e3ADRB1DZzzkMB/wGt+il5A9XcxNL8KwaX4o1rWo3Jm1RLdJY9oAHlBwDnuSH/QUuueF4Nc1fQdQlfbJpF091ENudzNC8RHXjiQ/lW1RTBaXt/VzD8TeFbfxNLpEk0rxNpt7HfR7P4mUEbT7EE07xAH1B4dHl0i6vtM1KOWG7uoZ0iS3TYfvfOsnzZwDGCQeuOtbVFTZNWew7636nien/ALOL/DuS4j+F+t2vhHTby0S0u7DVLKfV42CF9jRl7lGTAkYEZIPHAxWF8PvBviTwf4i8O2Wt60+seG/BdvLBHfJ4ZOnqrGERqDI9y7SpsfO6OMoNhywIr6JoquZ3vf8Ar/gXdhO0lZnyhZya78afjj4om8CeMbbVfAj6cLbUpNa0eTUdJ8/KBbaFDcRxynAdmZV43YJbIC9V4D/Z5+Ifw01LUZfDvxO0mw0m8ww0AeFnawtnHV4EN7ujz3VW2+iivoSlpL3Uku1v6/r8dRybk3f+v6/rQ5T4a+Dr3wT4fls9R1K31a/uLye9nurWy+yRM8jljti3vtHP945ql8TfhH4Z+Jmk3q6r4b0PVdWa0kt7W91SwineAkHGHZSygE54rsobyC4lmiimjkkhYLKisCUJAIBHY4IP41NUyipKz/roOMnF8y9f1OT8AfDHwz8OdPjj0Lw5o2iXUkEcd1NpVjFbmcqMZYooLc56+tSeFfAsPhTxH4p1S2unePXruO9ktWUBYpliWJmBzzuCJ+XvXUVm33ibSNLu2tbzVLO0uVhNwYZp1RxGDgvgn7ue9W5O7b6/8P8AoRGNlZf10Mqw8EJpvxA1TxPBfzKNSs4bW508gGIvEzFJQeoba7KfUY9KNa8Dpqnjjw/4nivprO70uO4t3iRQUuoJQMxtnph0jYEf3cd66BL63kslvFnjNq0fmibcNhTGd2fTHeq95r2nado0mrXV9b2+lxxee95LIFiWPGdxY8Yx3pfD8v8Ag/8ABGtdupheHPA9/oPiC71K48Z+INbgnDBdN1E2v2aHLZGzy4EfjoMueOuTzWppPhuHSda1nUo33SanJHJIu3GCiBB354FWdD13TvE2k2uqaTfW+pabdJ5kF1ayCSORfVWHBFX6LW0fQN9THXw3CviqbXRIRcSWa2ZUL/CHLA5+p9Ky/Cvge/8ADerXd5deM/EHiGKcELZ6qbXyYcnOU8qCNsjp8zHj866yihabf1cHrv8A1bQ57wx4MtfC2reJL61fLa5fC/mTbgLJ5McR785EYP41Jp3gbw/pHinVPEllpFra67qkccV7fwxhZLhUzsDkdcZ69enpW7RT7eWn6D3v5mFZ+E7ez8aan4jRz9pvrO3s5I9oA2xNKynPf/Wn8qr6p4Hg1q316O9uZJTqirGsiqFa2VR8gQ+qvucH1NdLRSeugXd7nLeIvAyeLvBcOg6vdm7kX7PI94YgC8sTo4k2g4GWQHGa1fE3h+28V+G9T0S9G601C2ktZRjPyupU/oat2OpWmqRPLZ3MV1GkjRM0LhgHUlWU47gggj2qzRL3rp9Qi3Bq3Qo6Zpaadotrp27zY4IFg3EY3AKFzj8KoeB/Cdt4F8K6doNm260sY/Ki+XGFySBjPYHH4U/xd4w0fwJokmsa7erp+mxyRxPcSAlULuEXOBwNzDnoO9aVnqFrqMbva3EVyiOY2aJwwVh1U47j0p3cm3/X9a/iSlypJbHN+MtFfxxb6h4ZubK+srCa3SaPXLeaICOdXBQIpYtvQqr5ZNp6ZPSuabwZ8VljaFPiPoMtvgqpuvCjvIV/22W9UE46kKAfQV6jTFmSRnRXVmThlByV+vpU2WxV2fMfg/8AZK8ZeC/DXifw/Z/EzTZ9I8QJ5M8F14XLm3h2FBHC32vIUKTjduI49K6jxR+zbrXiS2bRY/H02jeFhfSahFbabpoS+jlkVxIv2hpSjIxkc7TF0brkA17ZY6vY6nJcx2d5BdPbOI5lhkDmNiAwDYPBwQfxqh4u8YaR4E0OXWNdvV0/TYpI45LiQEqhdwi5wOBlhz0Hem9Uk/6/zHzS6ef/AATnvgz8Lx8IfBo8PR6j/aFtHcSywKsJhjt42OREiF3IUf73UnAA4Hd1XstQtdSjd7W4iuURzGzROGCsOqnHcelWKbbk7shJLYKKKKQwooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigApksqQRPJIwSNAWZm6ADqafTJYknjeORFkjYbWVhkEHsRS9B+p5j4Tv4tD8bNfzsILTxlma3ZyArTxZCAe8kADAekZrSm8WeMofjXB4eHhZZPA02km6/4SITcx3auQYSnPVSpGcd+tdxLY206wrJbxSLCweIMgIjYdCvoR7VPVaaeX9L7v0Qt7+f+fT+urOA8beLPGWh/ETwVpuieFl1nwxqck8Wsap521tOwoMbbepBIYdMdORXlv7VXwW0rxT4y+GPj59KtdS1DQ9etbG6gvIRNFPZXEojZWRgQdrOrAkcc19I1FcWsN5GEnhjmQMrhZFDDcDkHB7ggEfSiPuyjL+V3/Hb9PRjeqa6NW/4P9djyH9qDUdU0P4d2Nzoms6dpF5HqlqsVnqkW611IlsLaOQRsVzjLdAFOeK7TxV4Nj+Jfgi30zVLubS5nNvdG40adSYZ42WRTGzoVZQ6j7ykEDkV0GuaDpnibTJtO1jTrXVdPmG2W0vYFmicejIwIP4ipdL0uy0PT7ew060gsLG3QRw2ttGI44lHRVUAAAegpLZp97/gv8v8Ahuqe6a6K39f1+lvMP2b45dN8C6xo8t5PqF7pOvalbSy3WwTOTcPIpcIqqCyyK3CgfN0rc+Dfirxh4u8NXtz428Lr4U1eDUJ7aO1WbzFlgVv3coPT5gexI4rtbawtrOS4kt7aGCS4fzZmjQKZXwF3MR1OABk9gKsU73d32X36a/n94S1bfm3999Px/A4H4d+LPGOveKvGun+JvCy6Fpmm3yx6NfLNvGoW7LnfgcAgj179BijSPFnjG4+MWueH77wstt4Mg0+K50/xAs2TcTE4kiKjOMZ74PHQ5rvqKS0t5L79LX9eoPr5/hre36HA614s8Y2Pxh0DQrPwst54KvbGaS918TYNpcLyibO4YDvjr14xXZ6pDeXGm3Uen3MVnfNGwguJ4TMkb44ZkDLuAPbcM+oq3VXVLKTUtNubWK8n0+SaNkW7tdnmwkjG5d6suR2yCPal9m39f10Gviv/AF/XUfZrNHawR3UyT3SxqJZI02K7AcsFycAntk49a5f4k3NteeDNZhgu7c38MDTQRtfPbgzJ86BmjdWC7lGQDyMg8VxfxEt/HXgu+utZ0Q2vibT7qxg097e8Fyl7A43AyxtbQS7txYE/u1AK56cVj/CP9mXw9Z6DNd+NtB0PxXqd863CSato9rPcW6lFyjTG2ieQ5ySXQNzg0O8uazt/n/WoRag1df1/Whf+EPjaG28I+KNQtbD7RdSaib6LR7eeGKVzPBDNtUyOqjJkPJYA88103w/+PXhTx8dRtBdf2Frul/8AIR0XV3SG6tMjhmG4qyHs6kqexrS8QfBbwD4pkE2q+CvD1/dLAtvHc3Ok28skcajCqpdDgKOg6D0rH0j9mv4Y6ZpttbTeBPDOpzwoFa9u9Ds/OlI/ibZEq5+gA9qttdFZWSXy0/4f8yIppau73fz1f/AOC8dfH3wn8Ufhn8QrXw/eiSbR7Br+3uJiqx3SxuxEkXOSA8LDkDsehBPY/AeVo/8AhPYVVjCmvyXEPykBhNbwzHGevzSGui1P4H/DrWrw3moeAfDF9dsADPc6PbyOQBgDcUzwAK6+0sbbT0KWtvFbIxyVhQKDgADp7AD8BRGyu+rVvxT/AEKl71rdHf8AC36s5P4d/EjTvGfhmHUJNQso7vfJHcWolCvbOrkGJ1JyGXGDnuDXkV58TdJ1r9ozWPh3c2mmafpmoWqzzz20jWd9eyRpHIlx9oidS8XJi29QUIJwcV7F4h+D/gTxdqTahrngrw9rN+w2m61DS4J5SPQsyE1mf8M8/Cv/AKJr4R/8EVr/APG6jqm/6/r+u5Wlml/X9f12PO/gD4o0nTdY8ayXNro/hiCEKZYLApDa/uJbiBpUAOMEQAk/nWj45+Kmj/Ez9n3xhrelsbVLWCeS3F48atKYCJFkUBj8p2gjPPYgHiuv8Xfs9/Dzxh4Tbw/deD9Dhs47eS3tGh0yANZB8ktD8mEO47uOp61y3w2/ZL8B+DdJu7bWPC/hTxHcTXb3Ec7eHLeIQo2MRqG3nAIJzu6scADAFaNu+1tPv/r/ADFomnur/h/XzNb4BykSePIQCIF197iI7SARNbwzEjPXmQ15x4g/aO8Y2/gvXvifpdvpM/gfQtZl0y50WSCT7dcQRXHkSXCT7wqtuO4RmMggfe5r6Xs7C20+Mpa28VsjEErCgUHAAHT2AH4CvMrj9nLw3caleEX2qw+Hr69/tK78LxzRjTbi53iQyMvl+YMuAxVXCkjletPTmj2SS+635pP7/mpjpF31bbb+d/1a+75P1C2uFureKZAQsiBxnrgjNS0iqFUADAHAApaXoCvbUKKKKQwooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKAIprqG3/ANbKkf8AvsBRNdQ267pZY4xjOXYCvh/4uHwBc/tEfGWLXb6zuo18DIxttQvHlijvQzHCRsxVZABEQFAIJBGCc1h+Dde8A6p45+GWs+PdTtdR0bUvhoI76TWLl5rWS5SSGMqyOSiuCGGMAlgP4sUoe/FP+tp//IfiipLlbXb/AO0/+T/A+/JbmKGLzJJUjj/vswA56c1ICGAIOQa+FfCdsmj2vw1svi3DN/wq2ey1aKyXXo2NtbyNc5sRdb+Fb7PkRmToSMc19PeG7jQ/BHw703wp4X1x7y/bT7n+wY9UuvMuboRhiCpYAyIuVAYDG3bVS92Ll2v66X0fZ6Xt2ZK1ko/j09V3XmP+IvxibwH4+8B+G00ZtRj8T6g2nvfrdRotm4jZwGTl2JCnHAHHJ6V6FJqFtCwWS5hQk4AZwK/PzTdY8Fed8BtUe3nPjy3114vGDpbSvqSXBt5hKbraN+N+SrHhV+7gCsrSPhb4G8efsu/FnXdM0+HxL4i0TWtUbTrySeS7uLe285GRkLMSQY48hjknBIPJp8vKmpPa+vl7q+7XR9h7yilpeyt5vm/+R1R+ji3EUkjRrKjSL95AwJH1FENxFcbvKlSTacNsYHB9DXxZ/wAJJoOtfHvxbq/he8ks4dW+GeD4k0uxkeEXCs581pUXBdVTGSc5Tb1GKyPgLLpHiLxVp+o+G59L8PT6b4TliudI03xBHI+saltH+mNBbykSYXflpl35cZXIyE9L36Jv7nL/AOR/FeYt7edvxUX/AO3fh6H0p4u+Nl3Zw6jc6BYaV/Y+nS+RceIPE2qf2bpplBIaOOQRyO5UjBITbnIzkGtr4dfFZPGGpXWi6hb2tlrlrEJmWwvVvLWdOMtDKACQNy5DKrDcpxgivn288WaVpXxJ0430E19ofg7wPDrHhzSIoTIdRu5VYSTqP43RVAyfu+YxOKrfAXS9FuPgrpAh1VdJtrnRdSvtR1uxQqVvr3968cAAy7QoG3Bfu7FFPlcVK2tvzvJf+2v8Fux6Scel7fkn+F187vZH1f4p8ZaX4R8K6t4gvrhDp+m20lzO0bAnailiBz146Vyfw1+I3iXxdYXGp634Ys9I0ea1ivdNvbTVkuRcLIu4RSAqhjlUbcjlcnhjXy5dav4csvgr8XvCuv6R4OurXR9EWGLxNoMQXT7652yiKJomBCXiudxCliS4OelbFnf+A7OH4MJqdtpC/B660SUXBhgQaWda2RAfago2b8CUDf8Ax+4FJK7kk+1vmpP79NPO3cUtFHTvf5cv+bv5JvofRnwR+MH/AAtzwVd+ILvST4ba31O6017S4uUlKNDIYyWdflySOxI9zXoqssihlIZSMgg5Br89fAOqeFj8OdA8N6hpsv8AZreOdZW2/t6KWLRmBaXyhOHQ/aOCNiAj5wMkYr6D/Y38XaXY/Azwtod9rduNW+26hYW9rM5jlYxXEp8tI3JYBY9pC5OFxVWTjddl+Sv/AF5ifuv5v85W/BH0KtxE8zRLKjSqMsgYbh9RSG6hE4hMsYmIyI9w3Y9cV8B+B30TxN8SNB0k6xp2n+ILPxbfTar4mOvJaXmt2vmyiO0aOOVbksGMaiORQgEXGQcHS8Q6aureEfEFvcf6P+0TH4pkm0plyNTWH7YPJMbfeNp5B5/5Z43Z5zSiubl8/wD7X/P8CpLlbXb/AO23+78UfdAvrY+Zi4iPl/f+cfL9fSnm4iWHzjIgixu8zcNuPXNfJniz4f6Z4F+OGu+GoPDNpJY/FvT445JYrINFFdQt/pRcgYAaJzIM8F0Pc16P8Z9N8Ma98MZfCui+ItD0CPRLy3hNtdQCfT4miHmC1u4lIAiZF5BIGMdelS9IKX9b2f3dO4LWVv62uv1v2se1NeQRw+c08axf89C4C/nUqsGUEHIPIIr4d1HxloPjjw34G0/W/CmlaNFc6jqdvB5kry+GLuSOMKs0cZTM+/I8lPkAKtg8DPu37GOp/wBpfs2+DQ9215cWsElrM0hbejJK67CGJIwABg9BiqUdG+1vx/r8SG2rfP8Ar8/uPapJkh273VNx2jccZPpT6wfFknhuOHTv+El/s3yjfRCy/tJUI+1Z/deXu/5aZ+7jn0rF8TfGDw94V8E3niq9n26Tb3DWqytIiLJIJDHjczBVG8EZcqOMniovpf8Arp+OuxdtbHUXWtQWerWOnPFdNNeK7RyR20jwrsAJDyAbUJzwGIzzjOK0K8IuvGXiD4uN4Ov9L8BazYWEOqW+pQ662q6bJaiDkSN+5unZ1aNnGAp61t+PPiZ4n8K/HHwL4cgs9Pk8La8s0c0zOpuhIkcjkhfMBVVCpyEYHcclcDNqL0T3u1+F/wDgeqJvvbZK/wCL/wCHPU9S1CPS9PubyWOaWO3jaRktoWmkYAZwqKCzH0ABJrzjUfjdImpWWiab4S1a98TXyNcW+lytDCVtAwUXUzM+IkJP3G/ecEbMiqnx08aT+E9Y8DDSJb+/8QT6tti8PabLGsmpQeW/nBhIyqFVfm3MwAKjnnFeQat8PNe1vxJrniF/hN4u0zxH/aLX2g63Y6xpguLAPFGHjYfbAHjaVXYxtuUhz0JqI6tt7L/gbff+DW9mra0st9/z/wAvxT6NP13xl8YNZ8A+KJ4dV0yxk0mPRre+cW87eck7XKwygErho1Dq2cA8dOePW1YMoYdCM18qePLHx58RrNLrxH4NfwXcDwxeaVd6hqWp2RtXvJpLcw+X5c7NjfG33gOoHNfRviLUdU0Dwus+naHL4lvYljRtPtp4opJVOAxVpWVMgZOGYZx1q2rQTvrr+bt+FiNeby/4C/W5vCRWVWDAhuhz1p1fK0154l0y107w3ceB9X8L2kniq0utEmvtb00Law+ajyQ7VuWdhgXACKG+UgDpx6t+0Z4tPhL4dpe2d/dW+tNf2i6ZbafIonvpzMgECqxAZXBIbPAGTkYpW91S7u35fjra3kVbWy/rf8NN/wDI9SDBsgEEjg+1Rm6hWcQmWMTEZEe4biPXFeUfBbVL3xN4q8beIG0e60OwvJoIja3V/bXJ+1wq0cx/cSyKmAsakEg5U8V82+KNNTVvCfiy2vf9H/aGTxPJPojrkakIvta/ZzC33ja+STkD5Mbs80JXko9/80v1uJapvzt+e/3H3dRUVqJVtYROQZti7yOm7HP61LQJO6uFFFFIYUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFMlYxxuyoZGUEhFxlvYZrwi7/AGuNO07wvda7e+CvEdnb2Wvr4cvoZnshJaXDMiqzj7RjYTIvzAng5xjmhe8+Vb/8FL82l8wei5nt/wABv8kz3jYp6qD+FeWXnwf1m6/aAsfiMviW0TT7XS30n+xDpZLNE7rIzef5vDb1Bzs6cY71n+L/ANpBfButT21z4G8RXOlw6vBoja1byWRtRcTbNmQbgOFzIoLFRgmnR/tJ2kuoeONNHhHXP7W8KXlpZz2BktBJdG5bELQ/v8FSCD8xU84xninHdTj/AFdJflJfePWzj/W/+a/A9iZQwwRke9G0cHHI6V4frX7U1t4dsvHk+oeBfElvL4MSGfUrYvZGRoJAzCaPFxhkAUk8g8YwSCK7vwp8Tk8XeIl0y10PUI7Y6VbaqdTkkga3AnBKRfLIW34DHhdvH3ulCV9v66iemj/rb/NHa7RknAz9KAoXoAPwrgdI+LkPiDxRq2k6XoGqX9rpl3/Z9xqkPk+StwFDMhUyeYAAR85QLz1rwHwf8SLnX/Fnjbxr42j8Y+GYPC/iFrOyS31OE2sqhIUj05rWKVxLI7yFt2zksAJBjFKPvPTtf5af5r16dE29E352+ev+T9Op9PeOvCY8beDtW0Aahc6R/aFu0H2yywJYs91yCPwrm/Cvw78QQ3GmTeLfEVhr/wDZTb7FNO0j7AobyzHukzLJuO1j93YOeleL+EfjNqGifHb4rat4q/4SXSdB0nw3ZagdB1UxTG0Yu4PkJAzIwYKvO5jkkE8YHtPww+Mlp8StW1/R20TVPDmt6J5DXen6qIi4jmQtE6tFI6EEA8bsgjkCnFO3Muqv+LQpdU+n6pfhqhl78O/EeiGVfBHiq30O0llaVrDVtMOoW8JYkt5IWWJkBJzgsyjnAFb3hnwbLpd4dT1fU5Nd1tk8v7VJEsUcKnG5IYx9xSRk5LMe7HArl/iF8fNI+H+vXmlHSdV1ufTbEapqzaXHG406zJIE0gZ1LfdY7YwzYU8VVu/2jNFubXTD4b0PXfFl9f6c2rx6dZWgt7hbMNt85luWiwGP3R95uqg0k9Lr+t/8n9z7MbTvr/W3+a+9d0er7FxjaMdelGxduNox6Yrxuw/ai0HWtW8BQaRomsappvjJ5ILLVokhSC3njDGWGcPIrpIgRsrtOcYGTXa+HfiRHrOleItSvdG1DQ7HRbmeB5r0xOLhYs75Y/Kd8rweuDnjFEvdTb6X/DcW7SXX9b/5M7DaDwQMVHcW4uIJI9zRl1K704ZcjGR715la/Hyw/wCEDuvGF/4e1rTNFS1W8t5XSGY3cbsFj8vypHwzbh8rYIzyBR4a+Pem+JNF8Zzz6RqXh/VPCvGo6bqSxGSMtF5kZVondGDKR0YnsaJLRprYIu7VupU8K/BfxDo+lxeHdW8Y2+t+E4SCkDaQsV/KA4cCa480q+TncwiVjnOQea9b2rkHAz0zXgNj+0NbeApL7wfe6D4n8R+LND0Zdc1X7PbARsjndIYpZnVWClmAAOMLtGSMVtN+1FoN/r2laLoGgeIPEmp6poY8QWcdlaLHHNbHb92WV0Qt844zwRjOSAaf9fj/APIv7mC11/rp/wDJL7z2WjaOeBz14ryG3/aY8Pax4d0G+8PaXq3iPVdZjnlg0GyijS9jEDbbjzRI6onlt8py3JwBnIrvvAPjjT/iP4Q03xHpaXEdlfRl1iu4TFNGQSrI6HowYEH6UrPXyFfY6DaMAYGB04oAA6DFUNE1G51Szaa70u40mUSvGLe6eN2KqxAfMbMMMORznB5APFXJ1kaGQRMqSlSEZl3AHHBIyM/nSGPIDdRmvJNb/Z10a88WW+qaVNJoti8xuL/T7S7voY7mQtuZgkN1HEpOTnMbZJya7P4c+LB4t8LJdy3Hn3dtPNZXchtTbDzoZGjkIjLsVBK5GWPBHNdMJUaPzFYMmMhl5BFD0d+wa2cSrZaNY6bpUWmWtpDBp8UfkpbIgEYTGNuPSuR0f4I+CdA8R6h4gi0YXGsX0X2ea81G6mvHEROfLTznby0z/CmB04rj/G3xO1BdPtPEPhbWH1yHUhcW2g6TZWapFcXyQykxXcshJwXjIAURkMuCTmuFtr6P4hfs6+PtTvNa8Raj4tTTnfUtL1hTY3GmXEa+asKW6bfKGQNrDcWGDuNHVvtv/X5+q7l8r92K6vT+vy80+x7p4W+EfhTwb4iv9f0zSz/bd8Ns2o3lzLdT7M58tHldiif7C4X2rsa8Q8b6kfhX4D1XxKmqa3eaFrFt+9hadriTT5pYtsUlucF1BcqpXJALAjGDm/4JvNd0P4keG9A1XVL3UEn8IpLJ9sYFmuYpUWSRtoALESgE47VSTcuTtp+DbXyt+KMnJcvO+v8AnFL8/wAD0/WtAsfEVvFBfwmaOKVZ49sjIVdTlWBUg8VoUySeOHHmSLHuOBuYDNec3/xRWz+Mlj4NutW0vTvtEXm21qYZpp775CSnmYWOF12lguZGdQThcVK35V1K8+x3Unh/S5NWfVH020fU3g+yteNApmMOc+WXxnbkk7c45rmbH4OeDtN8Yr4qTSFk1yNfKt7i6uJZltVIxiCN2KQ56fu1XNdp5iCQR7l3kZC55x64ryj4/alo/iD4T+MreG+ju7jREju7uCzusTQNE6ygMUYMhwnHShaNW/ruPfQ9YAA6DFG0bs4GfWvOPgvr19q48YW1/czXb6frs0MLzHJWFo45Y1HsFkA/CsTXv2n/AA54furm5n0rVpfClnqX9kXviqGKM2Frdb9hRxv8zaHIUyBCgJ607fCurSf32/zS9SU7ptbJtfdf/Jv0PY6KajrIqspDKwyCOhFOpDCiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAK+ePiD+yzJ4+8Z+OJbnUbdPCfiPT0lGn7W82LV0jaJbrONu0RleOTuUHtX0PRSav/X9evqkylJx2/r+tvS6PGo/gfqmrfs43HgPX9Whv/E15ZMbnV1B2G+J3LMOAcK4XHGcKK5vwv8Asz63o/xM8KeMbvXLWS6axx4tihVsapeI3mW8qZHAjckDODtVRX0TRV8z5+db/wDD/wCf4LsiLLk5On/Df5fn3PGPiT8AZfHvxWsNdN3bJ4avNMfTfEWmSq2+/RHElttxx8rls56qxHenfBH4V+K/gv8ADlNGa8sfE+rLeiNJrq4eBI9PQhIUDCNiXSID5cYLE8gc17LRSj7qstv+Df8AryHL3tX/AFpb/L7l2PB9c+B2uah8ZNI8ZaXb6N4aube7a41HVtLvJ47jVYAGVLa4twnlvkbcyMxZcfKK5GL9nf4ia54a8bWOqz+HNG1DUfE8fi3SLrT7ye6SK6jaIpDMjwx5T91yynPzdOK+pqKUfctbp/mn+cU/l5u7k+Z3f9br8m16eiPmLWPgn8YPEHi7xn4rj17w34Y1XXPDttpMcGnvcTmOWKR2yJyiFFYMfmCEjdwOMnf+FPwe8YfDHxh428Q22meGlOvafYiGwg1G4IW6gV1bzZnhLOrB8+YQW4+7Xv1FNO239dfzZO+/9bf5I+Tfix4Z1r4kfGbxDbaDfaTZvb6DbabrtquunTpLlJS7tDITazF4wpGHURsu8884HUeF/h/4gg1bRPiF4F0zR7Webw+nhy40HVL6VbWOCCU+TLbzpE7OvBxuQb1ZTlTXs3iL4beEvF2pWuo654Y0fWNQtf8Aj3ur+ximli5z8rMpI5HauiVVjUKqhVUYCgYAFKPuxt/XX/5J+l9HcqT5nr5fhb/5Fetux4Dqn7M99ZfAu08L+HtWt4PGOnaofEFhq1yjLDHqDTmZzhcsIzvdMDnaa9M03Qdd8PaHY6HYW2l3VqunyC5vLyZwz3ZGSTEEIZHYuzEuCM9DXaUUbpro/wDK35W+5C6p9V/nf87/AHs+Xh+zb430W38bf8IZqGl+ArbVbeGK00PS9QuZLJ5FmDyzZKA2rSJujxCpxu3ZyK1PAP7Pnibw74o8USXUOgad4e8Q6hp2o3Frpt1PJLH9njG+LLxjzN7quXJBILZA6V9G0U0+X+vO/wCa226LQHre/wDXT+vv3Pnnxn8JfiJqnxe8b+J9Mt/DT6ZrHhf/AIR2zS61G4jmVtzN5sgW3YAZcjAJ+6PXjzDwvoHjn4c/Gf4XeF7aLw1e+LNH8AXFhLDLqEyWkipcRKHWQQlwSAG27PUZ719q1zs3w58KXPiqPxPN4a0iXxJGAE1h7GI3agDAAl27hxx1pQ91rt/wJr85scnzKV93b/239Io8P0H9m7xR8NNQ8KeJvCupaTqviewTUI9XtdTMltaXwvJxPIY3RXaIo4G35WyBg4r6F0f+0P7PiOpi3F62WkS13GNMn7oJ5bHTdgZ64HSrtFO+lv6QutzzjxZ458R+D10i91XQLiXTPtM4v28Oo+ovFGMiEmMRiQhs5bYh2kYyRzXnnhnUPH3xg8e6pLHrXiLwn4PjWT7JeWFuloxYMuxJLe+sN+4qxJZJGXK44r6FurWG+tZba5hS4t5kMckUqhldSMEEHqCO1VdE0DTPDVgtjpGn2ul2Sszi3s4VijDE5J2qAMk0o73f9f10G3poeReONNsPhv8ACvW/DN7a+NPGrayJw1xp1mJ727lmzuG+CNY4u3zOqqB61n/DfWdW+A3wT8PaLq3hTxBrGuJGRBp+k2gusvI7OsLSRARxBAwQswRBg44r3yijo13t9y7C0un2v97Pn3wX+zz4nvfD9td+IvH2v+H9Vm1KfWm0jQ/sJtLCeWV3CIz2rM+0SEEliCcmtfUP2aJtU1W61K5+J/jN726sW024mUaahmt2OSjgWYDY5wTyMnBGTXtdFDs+mn/At+WnoO7vdvX/AIN/z1PIvih8EdY8ceFfD/hjSPF39h6Fp8axXcVxYm5mvAiqsbeYssexlxuHBG7BI4xXobeE7CTxLYa9IrSanZWcljFKSP8AVyMjP26kxr+VbVFVzO9/V/fo/wACbKyXbQ+efi34T8G/Gz4mS+D/ABzqY019Ghg1DQrdZFgmaZic3cbsCJChATZgqOdwORjfh/Z4sV8YaR411HxTrnizWNIPmWr3dtpgkcBWATzY7WOTb8zfKHA5r0zxR4I8O+OLNbTxFoOm69aqcrDqVpHcID6gODV7RtF0/wAO6bBp2lWNtpun267IbW0iWKKNfRVUAAfSpj7q81/V/UqTv6bf8D0Pm3xD4R1T4zftC2GteHW8Y+CrHSLKS11LxBLaR2YnyGCQWqXMDO2SxZnHyfKuMnBHQRfsdaHp41eLSvG3i/SbPV7RrG+tYbm1mWeJmdnDPNbu5LNJId27PznBAr3+ihaJJf1f/hwu7try/D/htzA8J+CdN8GrqH9nrJvv5UnuJJCCzusSRAnAH8Ma14bd/s3+I28JeIvhtFdaVJ8P9c1WTUptSmmk/tGBJbgTyQLF5exuQQJDIMA/dOK+kaKd3zcz/rb/ACQlorL1+ev+bI7eFba3jhThI1CL9AMCpKKKQkrKyCiiigYUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRXOfELR9b1/wAJX1j4e8R/8Ilq8oXydX+yJdeRhgT+7chWyARz61Zk1p9PvbLTGVr65+yvcTTKAvyoAM7R3ZiMD6+lK/f+uozaqK6uorG1luJ5FighQySSMcBVAySfwrwn9mH4xT/Gi+8Y6yPF0Gs2Md1HDHoKaVJZvojgNmF5JADMxAUlhwCCBxWX+0n+0ppXwi8QS+G9U8c2XgttW0dnsNSXS5dUuLO5WQAs8EYPysjfLu4yp69KU24pd3t91/679BxV212dn99j0nxZ8XtJ/wCFP3HjXw1r+iPZTxqLDVdSlcWHmPII1MrICyqHODxx3xWxdfE3RdJ8Sad4d1G58rVr3TZNTiMcbNBJFFjzSsmMcbgcHkgivlT9lX9pLw3+0ZY678GfG8Fj4nuIo5PK1G10uS0sdZtAQxkMRVfJkBOSMAZ5Fdr+z9rHh/WPif488LaBrsWveF/Dlh9g0mKNhKbKN3IuLd33FiquihNwB2g9QAauSs2l1Ta9LP8AW34rR7zf3dejs/m1+l/62+ldB1q08SaLYatYSedZX0CXEEn95GUMp/I1fryH4cvL4P8A2YdLN3dzaW2m6CQbrygZIVSM7XCnuAAQD7V8o+G7jQfgl42sfFXxJ+PHjzUIre9ka70eDUbm8tNPusI8VpdLEh37kZzkIinYQOnNS5fauK0j3/r+r2XVD5ZKCe7/AMkfd3jrxrpfw68J6n4k1qSSHStOi864kiiaRlXIGQo5PWo5PiF4dh17RdEl1a3h1fWbdrrT7ORtslxGoBYqD1wCDjr19K+U/HP7fXwg8Sya7o//AAmTy+G9S0Ka3TGh3yyR3ZJHLGLkMrDHHBQ8815v48/b+0rQ/FXhbxb4b8bWvirR7WGG2v8AwRP4ZuILqEMoE08N4ycyDn5cqpAxz1qI6tX6/wDBX5r7n53RJaab6/8Atv8Am/mvLX7i8VfF7w14L8Qtour3clreLpU+skmFjH9mhIEjb8YyMjj3rr7a4ju7eKeJt0Uih1b1BGQa+Srr9pf4X/tEeLLTSPCOs3GqahceH9VtLmzm024h2RSQo5LGSMKSDGBgE9a+gPDevSeFvhF4evdRhka8TT7SE27fKzTuqIqHPQl2A56VSXu676fO7lt9y+ZLlHmSj1v8rKP+bZrv4+0iP4gR+DXklXXJdPOpRx+U3ltCH2Md/TIJHHXkV0defa9cfYvjN4RbeiNeaXfW7xbhuO1oHUgdwPmH/AhXjz/tQP4X/aG8f6T4i1iRfDGgaWbqfSU0mTzbCONoQLoSqCZll85/lX7ojHFTGzsr62k38m/0sU09WttLfOy/O/5bn1FRXgf7Jfj3RvH+n+PL7wz4nvPFXhpvEMs9jc38EsMkHmxpLJCBIqttWRnxx0Ncx+zn42+PmvfH74j6b8RdDNj4FtJG/smdrVYkUhwI1hkHMqsmSxJOD6dKrlfMoPR2v+CdvXX5ilZJyWqTt+O/+fY+o6KKKkAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKK5Gx17Vv8AhPH0vUrvSbOGSCaaz0238ya6uIkaMee0h2rGAX2mMK3UHf1FC1dg6XOuorgfg/4g1jXNP8Rxa3fxaheafrl3ZI0cAiKRAho0YA4JCuvzcZGO/J7TUNUs9KjjkvbqG0jkkWJGmkCBnY4VQT3J4Ao6J97P79g6tdm192haopM468V4f8ZvjdN8FfHCXmrX0b+GptHZ4tOaJEL3n2mKJGM7MBGv74bt2QAM9qOqXf8Ayv8A15jSb2PcaK5vwHd+I9R0UXviRdKiubgiWG30iV5oooyAQDKwHmH/AGgqj2rpKbVnZkp31QUVn3uuW2n6pYafKtwZ74uIjHbu8Y2rk73AKpx03EZ6CsL4ha5q/h/T0u7O60nS9MjBe91TVPMk+zqCNu2FMeZu5HLrjIPzdKQzraKqXOpW9nJBDJNGLm43CCAuFeYqpYhATycAmvP9W8e6rcX3gK+sGi03TdS1OSw1OyuljnlU+XJtQPFIVVxIgBwW64o62Do32/TU9LoorgfjD4i1jwvpvh680m+isVk12xtLszQCVZIJpliZcZGD84wQeMULVpd2l97sHRvt+h31Fcd8LvHFx468OXt/e20dlc2up3thJFGSVAhneNTk+qqrfjV3WPGsWnyafDYaZqGvTXw3xf2bEGiEe5QztMxWNQA2cFtzAHaGp9l3G1ZtPpf8NDpKK43UfHElv8RNE0O2azubG7S5iumWTM0FxGiSIpAPAKFiQefu1N4X8TXhtNWfxNPp2nz2180axRyqBDCxAhEh3n5mBB525yBiluI6yiorrzGtZhE2yXYdjYzg44NeOfB/4ra3rl94W0DXZrbUL290a8vJtQhi8oyTW90sDrsBIGA3OOp6AdKcfefKv60b/QTdlf8Arov1PaKKKiurqGxt5Li4lSCCNSzySMFVQOpJPSkMlorAm8WFfE0WjW2kandnAa4vlg2WturKSrGRyokyVxiPeQSMgA5rL0DxxLrXxE1rRY/slxpVvYW93a3ltJvLu0k0cqNg4+Uxr09TmnuHRvt/wx2dFJnHXijOOTwKQGD468C6J8SvC974d8R2f9oaPeBRPb+a8W8Bgw+ZCGHIHQ1xnxY/Z90n4rLojf8ACR+KPCN1pKNDDdeFtVaylkhO3MUhAO5flU+vHWu9vfE2nafr2naNNMw1HUFkeCFI2bKoMszEDCjkcsRknArTbJUgHBxwaXS/9dv+AO/Q4TQfgn4X8N+C7rwzZx3wtbomSa9lv5nvnkP/AC1+0FvMDjsQRjtWb8Gf2efC3wRTV5tKk1LWNY1ebzr/AFrXro3d9c4+6rSkD5VBwB+eTWN8AfiX4l8XalrOjeJJrO+l08OYr62h8l3K3lzAyumSMgQpyMZ3GvYLHULXUoWltLiK6jV2iZ4XDAOpKspI7gggjsRV6p37oTVrwfR/iSrEi8hFB9hWT4d8GaB4PW6GhaJp2ii7lM9x/Z9qkHnSHq77QNzH1PNcv8cNc1/w74HXUfDd7BY3sWo2aySXEAmQwvcIkoK5H8LHkEHitr4a+Jrvxh4J0zVb+KGC/mVluI7ckxiRHKNtzzjKnrUrZv5fkwfQ0PF3hm08Z+FdX0C+3Cy1K1ktJjGcMFdSpI9+a8C8D/Dn9ofwbrC6U/ivwDrXhqMop1vUNJuDq9xGoCqJUjdI2YKMbixr6UrjfEniPxCusto+k6fZWDyxstvqmsXSiKWUxsyiGFCZJSpUbwxj+XkE0L3XdD+Jcr/q5Y8K+AI/C+p6lfNrOras98dxh1G4EkUPzM2IlCjaPmx9FFdN5Ef/ADzX/vkV5bqHxO8Qabd+E9GntNJi8TXWqw2Oq2ZnkMXktDLIZrdtoYj92cbl6qynHWul+F/ja58daLqd1eW0dpc2WrXunNFGSRthnZEbnuVCn8aq3bp/wP8ANA01q+v63/yZ1yxIpyEUH2FYXjzwPpnxH8J6h4d1gTfYL1ArPbSmKWNgwZXRxyrKwBB9QKs+MNQvdJ8K6xfabHDLqFtaSzW8dxny2dVJUNjnGRUnhnWP+Eg8O6Xqe0J9sto7jaDkDcoOP1qLKSa7W/G/+QX5Wmt9fwt/meV+Bf2U/Cfg23v2vdW8S+L9Wu4Dbf254k1iW6vreIndtglG3ycHBygByBzxW58JfgHoPwhuNTvbXUtc8R6vqB2zat4k1Br66EQOVhV26IvYfmTXpdcF8bPEGs+GfA/9paFexWN3BqFkJZJoRKnkPcRpKCpI/gZuhB4qru689Pvf9XFa+nzO7VFQYVQo9hinVx/w78bT+Mv+EjS5gjt5tJ1efTtsZJ3Im0oxz3KsD+NdhS6J90n9+odWuza+52CiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAzfEGv23hvTTe3cV3NCHSPbZWktzJlmCg7I1ZsZPJxgDk4FeN3nwI17wj8RG+IPhfXLnxTr80syTaf4qvVht0tpRzDDLFbs8aqwRgpDD5exJNe7UUbO63H0t0PH/AATp3iLwXo/xB1DxJeeHvDmqateSarAtvftcW9mPs8ce+R5I4iRuj3H5cc1wHw91b4pfFj4JxJcWXhrxlaakLm3bUdUv5bMyhZCqTx+XaFZEOMqdkZ+Udc5r6E8VeB/DvjqySz8R6Fp2vWkbiRYNStUnRWHQgOCM1r29vFZ28cEESQwRqESONQqqoGAAB0FG979kvkv1/r0G3pbvc848ez6x4f8ACHhW4vbG611LC4tpNaj0qJppWCJzIkYG6QCQK20AkjselcR4r1fV/i94r0u48LeBBrOj2lpdWuojxtBPpNtcLKEAiWOW3eSTkZJ8vb8uM19BUUP3m3Lq7/erCj7qSXRW/rzPJ/gR4L8V+AYNb07WLLSdJ8N+YkukaVpupS3wsgQfNjDyQxbY87SqYO3LDOMAWda+OunWfw9vPFGm2r6ysV3JZpa2QkuHVlkMZaVYUeRVBUk4RiB2r0+vN/EnwB8HeKPGll4mutI08X8DB5P+JXZyG4YHILyPC0mR/ssOtEm5NArK7PIte8D+P/j7rfgDxzDaaPodtp00N9aXWn+IJ2LQl1dsxS6erglQVKh48g4bivUfjh8BoPjZa28N34m1nSre3hkRdPs3i+yTu2NrzI8bElSBgggjnHNepRxpDGscaqiKMKqjAAHYCnU3a3LHRJtr5jTd+Z72sfNuvax8RNc8XeFNJfQfBl74j8P3S3RNtr95IyZgdCZtliRbiRS2N5wcYGao6j8MfjPcxfZLHS/COjac+vvrkqWfiC487LKP3UbtYkIC4ZiwXPzHGDzX08FVWLAAE9TjrTqXW/X/AIKf6IWlkui0/Nfq/vPFvg14P8Z+B/FniS78U39pY6DqUcP9n6R/wkN1q7QzrvMziW5jRlDAr8i8Db2rzXQ9b+J/xkvvHPh+yn8N+J/D+n67bm219794o7do5RKYoVjtSJSgVAcucMT856L9Sa5oGmeJ9Ln03WNPtdU064XbLa3kKyxSD0ZWBBFJoXh/TPC+lW+maPp1rpWm242w2llCsUUY9FVQAKaet30/zT/QT1WnX/Kxz3hHwHJ4d0fxHYvdcatqF1eK0Ix5IlxwOBzkE/U1yWgQ/F3wfotlodvoHhHXLXToUtYNQm1y5s5J40UKrPCLSQI2ByA5FevUUlorLsl92iH1v5t/fqzwpPAHxB/4SCXximieGLTxCL9LgaXHq87W1wn2Z4Gd5/soZXwykDy2HyYzzxwvxO03x79s8VxanoXgu0vPGWnQWEVhb6/eXFyZIWcfaEiSx3Pt85MkAbQgJOOn1fTdqlgxALDoccimnaw4vl/rzufI/gT4mfF3VPjxrWnXek6CdRjsJEh8PzeJLiKG3hjkjTzWUWjZLH5kkKruWRhk7cD1P4U/B/XfDmqaDrGvPp9tfWI1cPa6dM88YW8ulnVFd40LBcHJwOe1ey7F3Fto3HjdjmnU1KyS6r/g/wCYu9tn/lY5D4oeIjofgPxHPaeINN8PajbWTyR6hqTqIbVip2u4OeMj0PToelcP8O18S/F79m7TH1XUhb+IdStjLHqEkOVfbKTDIyBY9ysqoThUyG6DpXpPifwH4a8bfZf+Eh0DTNc+yyebb/2jaRz+U4/iXcDg+4rcRFjRURQqqMBVGAB6VK2afW34X/r5A91bp/wDzCPW/jJHGqP4P8GTMowZF8S3SBvfb9hOM+mTj1Nc14Z8A/EHwLJFq2j6H4Ym1C8+1i+0uTWJ4re38y5aZDFMLVi/32yCi8nivdqKOtx9OXp/lsfN+reEfj3rWg2Om3cPg+T7PPLNJMuuXitODJvhX/j1+UxEKN3O7b0Gat634f8Ajzrul6pp01n4NS1vr0zgDXLwmK2KBXts/ZRuyckPxjd904r6FopWT/r0/wAv61Ftt/W/+Z89ftEeJ9V+Hnwk0bUtB1rSIvGNg8NlGZSslzeybdjW1uTFIxZ5NuRsyQDyn3gax4d+PuseJtF8SxXPhmyS1kjJ8NR6rcx2+zDCXzJRbnzWcNwCgCFQQTzn2a58A+GbzxPB4kuPD2lz+ILddkOqSWkbXMY6YWQjcOp6HvW/V3fxPe9/6/r/AIJZWUVta39f1f8AI+f/AAn4D+JngPUL/X7XR/C93fahPdyXOlnV7hIreOSXzVMcotWZ23NJkFB1GDXVfCfTPEFr8P8AxFqT6daaZqmtXdzqdpptu8+yFnRQFbzoonUs6liCg5avVqKi3uuK7W9Fv+aDeXM9739Xt+TPne88bP4q+FkPgXTvCXiqHxPcWsdpJFfaRcRQ2swK75ZLp1WF1VstuR2Lds1oX3hX4waDoE3h/wAK2vhZbeHUTeWurXer3MUrxm588xyQLbEDIJjJEh4Ocdq94oq3K7v53JUUjwbxJpPxr8XTywalovhi30RkwLLSfFt9ZTM3cvcR2YfHoEKe+azvh78Nfixb2vgvS/Gkfh/U4/D+qyXy66ut3NzeiIiVUi2vbLvISQIWaTJAyea+iqKUfd2/qxT1Vv61Vjw+bQfE/iT9pvTddu/B7WOgaFZz2dtrM08DrciRQS4CyGQMG+VVZAADId3zYr0fwJ4Pfwh/b++ZZRqWqz6gqoOIxJj5eg5yCfxrqaKS0SXZNfe7v8Ql7zu+9/uVvyPI/Avg3x1/wk3ii78UXFoba8uZ4IJor24l86zOfJC2xbyoGXOCwyz7ecZrhPGXhT4mW/gTSNFuNJsoo9JEVnZar4f8ValbXBf5Y45XghsnBHAJV96Lznjmvpeil0S9Pw/XV/eP7Tl11/H9NvuPNPg9cfELQ/Dsen/FW78Oyaur+Xa32kXTk3agE/vEeKMBwAMleDycLXk/jq41f4u/ELxtpnwzg03WLKTR4dM1bVr7U5YrKG8WVmjEQSKRZJY15YDH3lBPFfS2saLp/iHTZ9P1Syt9RsLhSk1rdRLJHIp6hlIwRTNB8P6X4W0uDTNG0610rToBtitLKFYokHoFUACrveXM+n/Da/1v6C0UXHv/AJ3/AK8jn/AfgmfwjqHii6muEmOs6gt8EQcR4t4oiOgzloyfxqTwvpvjWz1i7k8Q+INF1TTGB+z2+n6RLayxnPBaRriQNxxwo559q6yilfbyVvuVhW0t8wooopDCiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooA//2Q==" alt="" width="602" height="360" vspace="0" hspace="0" border="0" style="width:602px;height:360px;margin-top:0px;margin-bottom:0px;margin-left:0px;margin-right:0px;border:0px solid black;" /></p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteAr">ث‌. تمت مراجعة هذه النشرة في التاريخ الذي تمت فيه مراجعة النشرة بالشهر والسنة</label>
        </div>
        <div class="m-r-60">
            01-2016
        </div>
    </div>
</div>
    </div>
    <div id="M-div" class="box-data">


    <div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr"><i class="fa fa-info-circle"></i>&nbsp;Read this leaflet carefully before you start using this product as it contains important information for you</div>
    </div>
<div class="row clearfix ltr">

    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="MedicinalName">1. NAME OF THE MEDICINAL PRODUCT </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Relaxon™ Capsules
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="QualitativeQuantitativeComposition">2. QUALITATIVE AND QUANTITATIVE COMPOSITION </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Each capsule contains: Chlorzoxazone 250mg, Paracetamol 300mg.
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="DosageForm">3. PHARMACEUTICAL FORM </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Orange opaque cap and white opaque body, size '0' hard gelatin capsules, printed with
'Jamjoom' on cap and 'Re 1' on body in black, filled with white to off white homogenous
granules, packed in PVC-PVDC/AI transparent blisters.
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">4. CLINICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="TherapeuticIndications">4.1 Therapeutic Indications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>&ldquo;Relaxon&trade; exerts a fast pain relief and is indicated as an adjunct to rest, physical<br />therapy, and other measures for the relief of discomfort associated with acute, painful<br />musculoskeletal conditions.&rdquo;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PosologyAndMethodAdministration">4.2 Posology And Method Administration</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>The usual adult dosage is two capsules to be taken 3 times daily. For oral administration and<br />short-term use only.<br />Do not take more than 14 capsules in 24 hours.<br />Do not take with any other Paracetamol-containing products. Do not give to children under 6<br />years of age.<br />Do not exceed the stated dose.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Contraindications">4.3 Contraindications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Relaxon™ is contraindicated in patients with hypersensitivity to any of the component
formulation.
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialWarnings">4.4. Special warnings and precautions for use</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong>Warning:</strong><br />Serious (including fatal) hepatocellular toxicity has been reported rarely in patientsreceiving<br />Chlorzoxazone. The mechanism is unknown but appears to be idiosyncratic and unpredictable.<br />Factors predisposing patients to this rare event are not known. Patients should be instructed to&nbsp;report early signs and/or symptoms of hepatoxicity such as fever, rash, anorexia, nausea,<br />vomiting, fatigue, right upper quadrant pain, dark urine or jaundice. Chloroxazone use should<br />be discontinued if a patient develops abnormal liver enzymes (e.g. AST, ALT, alkaline<br />phosphatase and bilirubin)&nbsp;</p><p><br /><strong>Precautions:</strong><br />Drowsiness can occur with the use of Chlorzoxazone and may be additive to drowsiness from<br />the concomitant use of central nervous system depressants or alcohol.<br />There are no evidence proving that the use of Chlorzoxazone during pregnancy is harmless.<br />Safety and effectiveness in children have not been established.<br />Patients suffering from liver or kidney disease should take this medicine under<br />medical supervision.<br />&ldquo;Care is advised in the administration of Paracetamol to patients with severe renal or severe hepatic<br />impairment. The hazards of overdose are greater in those with non-cirrhotic alcoholic liver disease.<br />&bull; Do not take more medicine than the label tells you to. If you do not get better, talk to your<br />doctor.<br />&bull; Do not take anything else containing Paracetamol while taking this medicine.<br />&bull; Talk to your doctor at once if you take too much of this medicine, even if you feel well. This<br />is because too much Paracetamol can cause delayed, serious liver damage.<br />&bull; Patients should be advised that Paracetamol might cause severe skin reactions. If a skin<br />reaction such as skin reddening, blisters, or rash occurs, they should stop use and seek medical<br />assistance right away&rdquo;.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="InteractionsOtherMedicines">4.5. Interactions with other medicinal products</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>The medicinal products that may interact with Chlorzoxazone include zolpidem, citalopram,<br />duloxetine, gapapentin, clonazepam, pregabalin, oxycodone, topirama, tramadol and alprazolam.<br />Alcohol and other CNS depressants: They cause drowsiness that may be additive to that<br />induced by Chlorzoxazone.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="FertilityAndPregnantWarnings">4.6. Fertility, pregnancy and lactation</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Epidemiological studies in human pregnancy have shown no ill effects due to Paracetamol<br />used in the recommended dosage, but patients should follow the advice of their doctor regarding its use.<br />Paracetamol is excreted in breast milk but not in a clinically significant amount. Available published data do not contra-indicate breast feeding.<br />&ldquo;As for Chlorzoxazone, no data is available&rdquo;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="EffectsAbilityDriveMachines">4.7. Effects on ability to drive and use machines</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Relaxon&trade; should not be taken for drivers (as Chlorzoxazone causes drowsiness).</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="UndesirableEffects">4.8. Undesirable effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Adverse effects of Paracetamol are rare but hypersensitivity including skin rash may<br />occur. There have been reports of rare blood dyscrasias including thrombocytopenia and<br />agranulocytosis, but these were not necessarily causally related to Paracetamol.<br />&ldquo;Chlorzoxazone containing products are usually well tolerated. It is possible in rare<br />instances that Chlorzoxazone may have been associated with gastrointestinal bleeding.<br />Drowsiness, dizziness, lightheadedness, malaise, or over-stimulation may be noted by an<br />occasional patient. Rarely, allergic-type skin rashes, petechiae, or ecchymoses may develop<br />during treatment. Angioneurotic edema or anaphylactic reactions are extremely rare. There is<br />no evidence that the drug will cause renal damage. Rarely, a patient may note discoloration<br />of the urine resulting<br />from a phenolic metabolite of Chlorzoxazone. This finding is of no known clinical<br />significance&rdquo;.<br /><strong>To report any side effect(s):<br />Saudi Arabia:</strong><br />The National Pharmacovigilance and Drug Safety Centre (NPC)<br />Fax: +966-11-205-7662.<br />Call NPC at +966-11-2038222,<br />Exts: 2317-2356-2353-2354-2334-2340.<br />Toll free phone: 8002490000<br />E-mail: npc.drug@sfda.gov.sa<br />Website: www.sfda.gov.sa/npc<br /><strong>Other GCC States:</strong><br />Please contact the relevant competent authority.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Overdoes">4.9. Overdoes</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><u><strong>Paracetamol</strong></u><br />Liver damage is possible in adults who have taken 10g or more of Paracetamol. Ingestion of<br />5g or more of Paracetamol may lead to liver damage if the patient has risk factors (see below).<br /><u><strong>Risk factors</strong></u><br />If the patient<br />a, Is on long term treatment with carbamazepine, phenobarbitone, phenytoin,<br />primidone, rifampicin, St John&#39;s Wort or other drugs that induce liver enzymes.<br />Or<br />b, Regularly consumes ethanol in excess of recommended amounts. Or<br />c, Is likely to be glutathione deplete e.g. eating disorders, cystic fibrosis, HIV<br />infection, starvation, cachexia.</p><p><br /><u><strong>Symptoms</strong></u><br />Symptoms of Paracetamol overdosage in the first 24 hours are pallor, nausea, vomiting,<br />anorexia and abdominal pain. Liver damage may become apparent 12 to 48 hours after<br />ingestion. Abnormalities of glucose metabolism and metabolic acidosis may occur. In severe<br />poisoning, hepatic failure may progress to encephalopathy, haemorrhage, hypoglycaemia,<br />cerebral oedema, and death. Acute renal failure with acute tubular necrosis, strongly<br />suggested by loin pain, haematuria and proteinuria, may develop even in the absence of severe<br />liver damage. Cardiac arrhythmias and pancreatitis have been reported.</p><p><br /><u><strong>Management</strong></u><br />Immediate treatment is essential in the management of Paracetamol overdose. Despite a lack of<br />significant early symptoms, patients should be referred to hospital urgently for<br />immediate medical attention. Symptoms may be limited to nausea or vomiting and may not<br />reflect the severity of overdose or the risk of organ damage. Management should be in<br />accordance with established treatment guidelines, see BNF overdose section.<br />Treatment with activated charcoal should be considered if the overdose has been taken within 1<br />hour. Plasma Paracetamol concentration should be measured at 4 hours or later after ingestion<br />(earlier concentrations are unreliable). Treatment with N-acetylcysteine may be used up to<br />24 hours after ingestion of Paracetamol; however, the maximum protective effect is obtained up<br />to 8 hours post-ingestion.</p><p>The effectiveness of the antidote declines sharply after this time. If required the patient should<br />be given intravenous N-acetylcysteine, in line with the established dosage schedule. If vomiting<br />is not a problem, oral methionine may be a suitable alternative for remote areas, outside<br />hospital. Management of patients who present with serious hepatic dysfunction beyond<br />24h from ingestion should be discussed with the NPIS or a liver unit.</p><p><br />&ldquo;Chlorzoxazone<br />&bull; Symptoms<br />Initially, gastrointestinal disturbances such as nausea, vomiting or diarrhea together with<br />drowsiness, dizziness, lightheadedness or headache may occur. Early in the course, there may<br />be malaise or sluggishness followed by marked loss of muscle tone, making voluntary<br />movement impossible. The deep tendon reflexes may be decreased or absent. The sensorium<br />remains intact, and there is no peripheral loss of sensation. Respiratory depression may occur<br />with rapid, irregular respiration and intercostal and substernal retraction. The blood pressure is<br />lowered, but shock has not been observed.</p><p>&bull; Treatment<br />Gastric lavage or induction of emesis should be carried out, followed by administration of<br />activated charcoal. Thereafter, treatment is entirely supportive. If respirations are depressed,<br />oxygen and artificial respiration should be employed and a patent airway assured by use of an<br />oropharyngeal airway or endotracheal tube. Hypotension may be counteracted by use of<br />dextran, plasma, concentrated albumin or a vasopressor agent such as norepinephrine.<br />Cholinergic drugs or analeptic drugs are of no value and should not be used.</p>
            </div>
        </div>
    </div>

    <div class="col-xs-12">
        <label style="float: left">5. PHARMACOLOGICAL PROPERTIES</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PharmacodynamicProperties">5.1. Pharmacodynamic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><u><strong>Paracetamol:</strong></u><br /><strong><u>Analgesic:</u></strong><br />The mechanism of analgesic action has not been fully determined. Paracetamol may act<br />predominantly by inhibiting a prostaglandin synthesis in the central nervous system (CNS)<br />and to a lesser extent through a peripheral action by blocking painimpulse generation. The<br />peripheral action may also be due to inhibition of prostaglandin synthesis or to inhibition of the<br />synthesis or actions of other substances that sensitise pain receptors to mechanical or chemical<br />stimulation.</p><p><u><strong>Antipyretic:</strong></u><br />Paracetamol probably produces antipyresis by acting centrally on the hypothalamic heatregulating<br />center to produce peripheral vasodilation resulting in increased blood flow through<br />the skin, sweating, and heat loss. The central action probably involves inhibition of<br />prostaglandin synthesis in the hypothalamus.</p><p><br /><strong><u>Chlorzoxazone:</u></strong><br />&ldquo;Chlorzoxazone is a centrally-acting agent for painful musculoskeletal conditions. Data<br />available from animal experiments as well as human study indicate that Chlorzoxazone acts<br />primarily at the level of the spinal cord and subcortical areas of the brain where it inhibits<br />multisynaptic reflex arcs involved in producing and maintaining skeletal muscle spasm of varied<br />etiology. The clinical result is a reduction of the skeletal muscle spasm with relief of pain and<br />increased mobility of the involved muscles. Blood levels of Chlorzoxazone can be detected in<br />people during the first 30 minutes and peak levels may be reached, in the majority of the<br />subjects, in about 1 to 2 hours after oral administration of Chlorzoxazone. Chlorzoxazone is<br />rapidly metabolized and is excreted in the urine, primarily in a conjugated form as the<br />glucuronide. Less than one percent of a dose of Chlorzoxazone is excreted unchanged in the<br />urine in 24 hours.&rdquo;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
                <label style="float: left" for="PharmacokineticProperties">5.2. Pharmacokinetic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><u><strong>Absorption and Fate</strong></u><br />Paracetamol is readily absorbed from the gastro-intestinal tract with peak plasma concentrations<br />occurring about 30 minutes to 2 hours after ingestion. It is metabolised in the liver and<br />excreted in the urine mainly as the glucuronide and sulphate conjugates. Less than 5% is<br />excreted as unchanged Paracetamol. The elimination half-life varies from about 1 to 4 hours.<br />Plasma-protein binding is negligible at usual therapeutic concentrations but increases with<br />increasing concentrations.<br />A minor hydroxylated metabolite which is usually produced in very small amounts by mixedfunction<br />oxidases in the liver and which is usually detoxified by conjugation with liver<br />glutathione may accumulate following Paracetamol overdosage and cause liver damage.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PreclinicalSafetyData">5.3 Preclinical Safety Data</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>There are no preclinical data of relevance to the prescriber additional to that already covered in<br />other sections of the SPC.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. PHARMACEUTICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ExcipientsList">6.1 Excipients List</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>1. Sodium Lauryl Sulphate<br />2. Colloidal Silicon dioxide (Aerosil 200)<br />3. Magnesium Stearate<br />4. Crospovidone</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Incompatibilities">6.2. Incompatibilities</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>None stated.&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ShelfLife">6.3. Shelf Life</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                3 years (36 M).
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PrecautionsStorageConditions">6.4. Special precautions for storage</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Do not store above 30&deg;C</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ContainerContents">6.5. Nature and contents of container</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>30 capsules of Relaxon Capsules are packed in PVC-PVDC blister with Aluminum printed foil.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialPrecautionsDisposal">6.6. Special precautions for disposal and other handling</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p> Keep out of tile reach and sight of children<br /> Do not store above 30&deg;C.<br /> Do not use Relaxon&#39;&quot; after the expiry date which is stated on the carton. Do not use<br />Relaxon&#39;&quot; if you notice change in medicine color or odour. Medicines should not be<br />disposed of via wastewater or household waste. Ask your pharmacist how to dispose of<br />medicines no longer required.<br />These measures will help to protect the environment</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="AuthorizationMarketingHolder">7. MARKETING AUTHORISATION HOLDER</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Jamjoom Pharmaceuticals Company
Plot No. ME 1:3, Phase V, Industrial City, Jeddah
Postal address:
P.O. Box 6267
Jeddah 21442, Saudi Arabia.
Tel: 00966-12-6081111
Fax: 00966-12-6081222
E-mail: jpharma@jamjoompharma.com
Website: www.jamjoompharma.com
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="RevisionDateText">8. DATE OF REVISION OF THE TEXT</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                24-Nov-2016
            </div>
        </div>
    </div>
</div>

            }    </div>
    <div id="f-div" class="box-data">
        
<div class="row clearfix rtl">
    <div class="container-fluid">
        <!-- Basic Example -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>صورة المنتج على الرف</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic" data-slide-to="0" class="active"></li>
                        <li data-target="#carousel-example-generic" data-slide-to="1" class=""></li>
                        <li data-target="#carousel-example-generic" data-slide-to="2" class=""></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                            
                                <img src="/images/nodrugimags.png">
                        </div>

                    </div>

                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# Basic Example -->
        <!-- With Captions -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>الصورة الاساسية</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic_2" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic_2" data-slide-to="0" class=""></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="1" class="active"></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="2"></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                                <img src="/images/nodrugimags.png">
                        </div>
                    </div>
                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic_2" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic_2" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# With Captions -->
    </div>
</div>


    </div>

    <!-- #END# Tabs With Custom Animations -->
</div>
        <a style="background-image: url('../images/banner.png');"
           class="scroll-top">
            <img style="margin: 15px;" src="/images/icons/up-arrow2.png" width="35">
        </a>

        <div class="footer navbar-fixed-bottom">
            <small style="color: white; margin-left: 30px;">All Rights Reserved - SFDA &copy; 2020</small>
            <br class="visible-xs visible-sm"><br class="visible-xs visible-sm">

        </div>
    </section>


    <script src="/lib/json2/json2.js?v=w3DjWhUtDqy3bSJKv285C-2kagUtW9F64T9z3xRah8g"></script>
    <script src="/lib/jquery/dist/jquery.js?v=w4hyv6-vmv08RC2hK00wXgxDziKII9paMAbU_M-5dgY"></script>
    <script src="/lib/bootstrap/dist/js/bootstrap.js?v=T574NvJTWc-Pan8hAmnXXc0eZFiqKRp7xQ3sz5QiFOk"></script>
    <script src="/lib/moment/min/moment-with-locales.js?v=5f0RFtuChrGi6osDzegxXWf5yOkmx45i7J9fM1p6P5w"></script>
    <script src="/lib/jquery-validation/dist/jquery.validate.js?v=ZDzsHzuLAtqQVxXwbgRtfAPXQ7UAoJRXBAUDvc9G9CI"></script>
    <script src="/lib/blockUI/jquery.blockUI.js?v=KKcUNqwNyTLaXzvuMyFk6JisiQq6Hk7ZtrciXnEf3Z0"></script>
    <script src="/lib/toastr/toastr.js?v=s1ewxfN8Vn23TAVRLUk8XiQUAw6uWhhuPO9dmtYzUiA"></script>
    <script src="/lib/sweetalert/dist/sweetalert.min.js?v=aPktydUv1rN3mouQeXoKi3ioFTIQlULuqYeoTAA2ihY"></script>
    <script src="/lib/spin.js/spin.js?v=b1plKpQIB-XuGyjWec42MhmhpPzEPzFI3OC8Ia0XIoc"></script>
    <script src="/lib/spin.js/jquery.spin.js?v=i7H7HL08ldqUANgfQInE7LlU2uWUdQMCJ-Q7-_zLutY"></script>
    <script src="/lib/bootstrap-select/dist/js/bootstrap-select.js?v=tXulJKckrq2j2wo8a9hvmXLDEQwhGviPTIYmEzy1dNI"></script>
    <script src="/lib/jquery-slimscroll/jquery.slimscroll.js?v=ESVSX4dkOxamaRoYfcqPM2FfErhgfxS60fp1Fa8ou1w"></script>
    <script src="/lib/Waves/dist/waves.js?v=ZOMv1vwqpT_ezNZGhvr9jJTr_jqu3lYHB7vmpxD7HmA"></script>
    <script src="/lib/push.js/push.js?v=w347yqiscLjM_TxUKpqeUA1LDR3w5vshQpxpTsgkLhE"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/abp.js?v=EjNSmvtPSqCVK_xG_aTvOp8hmVM_7vwyd3hg45CAMGk"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.jquery.js?v=XEXcdRYb4eN3XoQCbnM-BSR6UifHRLsXYDIVFZ7Oc6Q"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.toastr.js?v=h3viOCmHM1K7HnYUuJPDvLchk2Ge8CoKvl6ZJfICgII"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.blockUI.js?v=vMuHbqHh635SKL2RG2qsGGCDyHg1yFeGqhPKpS34g4k"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.spin.js?v=djoKib6ssm5DDzbXLe5pD7ayfFg3siaoEk-BFYzQlvI"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.sweet-alert.js?v=fPp3O_ILaqD0UHiR721w1i4iBtxo3NH7yfldI5dg0_I"></script>
    <script src="/js/admin.js?v=nakObLuf3yPs2VlWrIris5w-48c36X3YIRrxIis7IKQ"></script>
    <script src="/js/main.js?v=x_HDlXByl0okIi4i04d4Q_fNr85GPQi1W8gjs82s-n8"></script>
    <script src="/view-resources/Views/Shared/_Layout.js?v=36YkLzPJaGejZMB10f2T6f1rMVIzDKq96kjfcnxcLVg"></script>


        <script src="/lib/jquery-validation/src/localization/messages_ar.js?v=6kzy-p-PtvkHPWdHWyjMOIfwhBFlUYYv9jnF7zJnpUI"></script>

    <!-- Dynamic scripts of ABP system (They are created on runtime and can not be bundled) -->
    <script src="/AbpServiceProxies/GetAll?v=638865394571695575" type="text/javascript"></script>
    <script src="/AbpScripts/GetScripts?v=638865394571695575" type="text/javascript"></script>
    <script src="/lib/signalr-client/signalr.min.js?v=1yGr-J4NjYMQVt6LP6vocjHIWhO-BFQLfdCs8x1Mv-U"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.signalr-client.js?v=jTdZBAadu6DXq0iDTFX6vsn4q6bFhKm3XfN8Jz6dSmg"></script>
    
    <!-- View specific scripts -->
    
    <script src="/view-resources/Views/Home/Index.js?v=mAIakROmG_IlahImCtfrMSdaLPTG5Uoh6Z0hM1g3cxw"></script>
    <script src="/view-resources/Views/Home/Result.js?v=0pEgOuTQc8ZyJaaOpJCG7ytkKSCkzEMYCHEJfKDWu4k"></script>
    <script src="/view-resources/Views/Home/DrugsSearch.js?v=04aRniTG_ClH5tABzf7EDwQgWVpkDNpjeJUDSGvOK_Y"></script>

</body>
</html>